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Lactoferrin (LF) is an iron-binding glycoprotein of molecular mass ca. 80 kDa 
that is predominantly found in mammalian body fluids. Lactoferrin is a multifunctional 
protein that has a wide range of properties such as antibacterial, antiviral, anti-
inflammatory, and anti-allergic functions. Tyrosine residues in the protein play a part in 
many lactoferrin functions. Protein tyrosine nitration modification represents an oxidative 
and nitrosative stress process which can be caused by the exposure of proteins to 
oxidants from air pollution or disease. Understanding the way nitrated lactoferrin 
interacts with the biochemical environment of the body is thus important to the broader 
goal of understanding and preventing lactoferrin-related diseases, including certain ocular 
diseases. The main goal of this set of linked studies was to investigate the process by 
which LF may be nitrated, to observe changes in its protein structure and function, and to 
investigate a possible route to block the nitration process.   
In the first project discussed here, nitrated lactoferrin was synthesized using two 
different nitration agents: sodium peroxynitrite and tetranitromethane. After nitration, 
spectroscopic analysis showed formation of nitrotyrosine with an increase in absorbance 
intensity at 350 nm, as well as attenuation in fluorescence intensity at an excitation 
wavelength of 280 nm. A sandwich ELISA protocol was developed to quantify the 
amount of nitrotyrosine in nitrated lactoferrin samples. The results show that the increase 
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in the amount of nitrotyrosine depends on the molar ratio of nitrating agents added to the 
reaction. This study represents the first time that nitrotyrosine in lactoferrin had been 
selectively detected. In the second project, a broth microplate antibacterial susceptibility 
assay was applied to determine changes in the antibacterial function of lactoferrin 
brought about after nitration. The results reveal a reduction in the naturally present 
antibacterial activity of LF, which scales linearly with the increase in nitration molar 
ratios. In the third project, ergothioneine was used to inhibit the nitration reaction using 
several protein models, as well as to examine it as a potential therapeutic target for 
nitrosative stress-related diseases. The results illustrated that ergothioneine diminished 
the nitration production and protected the protein antibacterial activity. Collectively, 
these findings suggest that the nitration of tyrosine residues within lactoferrin can be 
important with respect to several physiological processes. Thus, further understanding the 
interaction between nitrated LF and the biochemical environment may aid in future 
research toward clinical diagnoses and in the development of therapies for diseases 
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Chapter one: Introduction 
1.1 Overview of lactoferrin  
1.1.1 Background of lactoferrin 
Lactoferrin (LF) is a protein found widely within the physiological system of 
mammals. LF was discovered in 1939 by M. Sørensen and S. P. L. Sørensen in bovine 
milk. An alternative name for lactoferrin is lactotransferrin due to a similar structural 
homology to transferrin, (Masson, et al. 1971). This name was proposed by Blanc and 
Isliker in 1961 (Blanc, et al. 1961). It exists in mammals and is found mainly in granules 
of neutrophils and is present in secreted fluid such as tears, milk, and saliva (Masson, et 
al. 1966). It is produced by acinar epithelial cells and neutrophils (Baggiolini, et al. 1970; 
Spitznagel, et al. 1974). 
1.1.2 Structure of lactoferrin 
LF is a monomeric glycoprotein with molecular weight 80 kDa and containing 703 
amino acids residues (Metz‐Boutigue, et al. 1984) . It consists of two globular lobes (C 
and N) which are connected via an α-helix (Metz‐Boutigue, et al. 1984; Adlerova, et al. 
2008). The net charge of LF is positive (González-Chávez, et al. 2009). LF is able to bind 
and transfer non-heme iron (Fe3+) ions (Metz‐Boutigue, et al. 1984; Baker, et al. 1990) . 
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1.1.3 Iron binding sites on lactoferrin structure 
Each globular lobe has identical composition and function. The lobes contain two 
domains: the N-lobe has N1 and N2 domains and the C-lobe has C1 and C2 domains, e.g. 
Figure 1. a in (García-Montoya, et al. 2012). Each globular lobe in LF has one active 
binding site to bind to Fe3+, which makes each mole of LF bind to two moles of Fe3+ 
(Adlerova, et al. 2008). The binding site in each lobe comprises of four amino acids 
which are: two tyrosines (Tyr), one aspartic acid (Asp), and one histidine (His). 
Particularly, Asp-61, Tyr-93, Tyr-193, and His 254 in the N-lobe and Asp-396, Tyr-436, 
Tyr-529, and His 598 in the C-lobe (Anderson, et al. 1989b). These amino acids provide 
negative charges to balance the Fe3+ charge via the two phenolate oxygens from Tyr, one 
carboxylate oxygen from Asp, and one imidazole nitrogen from His, and the arginine 
(Arg) side chain with the N-terminus helix provides positive charges to balance CO32- 
charge, shown in Figure.1 b in (García-Montoya, et al. 2012).  
The N-lobe of the protein has an open binding cleft which closes when it binds to 
metal. The C-lobe cleft remains closed with or without binding to metal. Also, LF 
changes the form of the lobes due to binding. LF has a closed form when it binds to Fe3+; 
LF has an open form when it is free to bind, shown in Figure 1. A and B in (Latorre, et al. 
2010). LF has three iron binding forms: not bound to iron (apolactoferrin), and bound to 
two irons (hololactoferrin) (Latorre, et al. 2010).  
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1.2 Lactoferrin function 
1.2.1 Lactoferrin function dependent on iron 
LF receptors bind to iron in LPS (lipopolysaccharide) within the bacterial wall 
and inhibits the growth (Krewulak, et al. 2008). Also, LF binds to glycosaminoglycans of 
eukaryotic cell and prevent viruses from binding, see Figure 3 in (González-Chávez, et al. 
2009).   
Some biological functions are determined by LF, such as antioxidant properties 
provided to the cell via the production of hydroxyl radicals within leukocytes 
(Kanyshkova, et al. 2001). LF shows some of these biological functions because of the 
iron-binding capacity of the protein.  The  antioxidant function of LF, for example, 
relates iron-binding properties to hydroxyl radicals production in leukocytes, which the 
protein accomplishes without releasing O2 and H2O2 (Kanyshkova, et al. 2001).  
1.2.2 Lactoferrin function independent of iron 
LF is able to attach to the surfaces of many types of cells via surface properties 
such as monocytes (Birgens, et al. 1983). The main part of LF molecule that binds to the 
cell surface is the N-terminal lobe. For example, LF competes with binding activity of 
lipopolysaccharides (LPS) in the bacteria wall to bind to immature dendritic cells from 
(CD14) receptors deficient mice and prevent inflammation (Baveye, et al. 1999).   
1.2.3 The surface properties of lactoferrin 
The LF protein has an isoelectric point (pI~ 9) which makes it a cationic surface. 
Additionally, LF has properties to bind to the macromolecule independent from the iron 
binding site (Baker, et al. 2009). Several of LF antimicrobial functions are associated to 
the surface cationic charge, which is mainly in the N-lobe (Valenti, et al. 2005).    
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1.3 Lactoferrin functions.   
LF has two known mechanisms for antibacterial functions. The LF antibacterial 
mechanism that remains unknown is the interaction which prevents the bacteria from 
attaching to the host cell receptors (González-Chávez, et al. 2009). The bactericidal 
function shows the direct interaction of charge on the LF molecule, e.g. Figure 5 in 
(Baker, et al. 2005) to the bacteria surface (Baker, et al. 2005). The bacteriostatic  
function is related mainly to iron-binding properties which inhibits bacterial growth via 
binding to the iron in the environment which is essential for the growth (Jenssen, et al. 
2009). LF shows bacteriostatic action against E. coli, B. subtilis, B. stearothermophilus, 
S. albus, S. aureus, and P. aeruginosa (Oram, et al. 1968; Masson, et al. 1966).   
1.3.1 Anti-inflammatory properties 
LF is called an acute-phase protein because it increases in concentration during 
most of the inflammation reaction (Kanyshkova, et al. 2001). LF plays a crucial role in 
inflammation by inhibiting the inflammation receptors (Conneely 2001). By binding to 
specific receptors of the target cell surface, LF protects them from the damage by 
oxidative radicals such as monocytes, macrophages, and hepatocytes (Brock 1995). Also, 
it inhibits the production of tumor necrosis facor-α (TNF) and interleukin-1 (IL-1) in the 
inflammatory process (Crouch, et al. 1992).  
1.3.2 Antioxidant properties 
LF in tears protects the corneal epithelial cells from UV damage through 
inhibition of hydroxyl radical formation (Shimmura, et al. 1996). Furthermore, LF has an 
antioxidant affect through the iron-binding site to prevent the production of the hydroxyl 
radical (Wakamatsu, et al. 2008).   
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1.3.3 Antibacterial mechanisms of lactoferrin  
a. Bactericidal mechanism 
The cationic charge in LF at the N-terminal binds to the bacteria anion surface 
lipopolysaccharides (LPS) and causes membrane damage (Roşeanu, et al. 2010). This 
cationic nature is concentrated on the N-terminus at residues 1-7, the first helix at 
residues 13-30, and the inter-lobe region, see Figure 2.A and B in (González-Chávez, et 
al. 2009). 
b. Bacteriostatic mechanism 
The LF iron-binding site binds to the membrane of gram negative bacteria to 
destabilize the membrane organization. The bacteria A. actinomycetemcomitans requires 
magnesium cations to organize the membrane by stabilizing LPS and protect the bacterial 
outer membrane which plays a role in the metabolic function (Kalmar, et al. 1988). 
1.4 Protein nitration  
1.4.1 Tyrosine nitration reaction 
The protein Tyr nitration is the result of covalent reaction by the addition of nitro 
group into the ortho position in aromatic ring (Riordan, et al. 1966). The specific Tyr 
nitrating reagent is tetranitromethane (TNM) which produces mainly 3-nitrotyrosine 
(NTyr) (Sokolovsky, et al. 1966). Also, the peroxynitrite (ONOO-) reagent used nitrate Tyr 
and other amino acids, and it is suitable for in vivo study (Franze, et al. 2005; Shuker, et 
al. 1993).  
1.4.2 Nitration protein and biochemical properties 
In vivo protein nitration is caused by reactive nitrogen species (RNS) including 
peroxynitrite (ONOO-) and nitrogen dioxide (NO2) to produce 3-nitrotyrosine (NTyr) 
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(Aulak, et al. 2004). The NTyr is used as a marker to the protein function alteration in many 
physiological and pathological systems (Turko, et al. 2002; Good, et al. 1998; Kim, et al. 
2002; Franze, et al. 2003). After nitration, the pKa value of protein changes from pKa 10 
to 7 due to the addition of NO2 in the protein structure, shown in Figure 1 in (Radi 2013). 
The reduction on pKa affects protein function (Begara-Morales, et al. 2013). Nitration 
makes the protein hydrophobic and adds steric hindrance to the protein structure (Savvides, 
et al. 2002). The nitration process changes protein conformation. For example, α-synuclein 
protein showed changes in folding conformation in vitro (Uversky, et al. 2005). 
Additionally, nitration has been shown to form the protein oligomerization structure 
(Kampf, et al. 2015). These changes in the chemical properties can play an important role 
in protein activity dysfunction.  
1.4.3 Protein nitration health implications 
The protein nitration has been reported with direct correlation to diseases such as 
cardiovascular disease (Turko, et al. 2002), neurodegenerative disease (Good, et al. 1998), 
and ocular disease (Kim, et al. 2002); and indirect exposure to substances such as birch 
pollen which linked to the increase in allergenic diseases (Franze, et al. 2003). These 
implications highlight the need for further investigation in the biochemical properties of 
protein nitration to explore the function changes or addition in the protein. 
1.5 LF nitration modification  
1.5.1 The effect of chemical modifications to LF function 
Protein chemical modification has previously been used to study LF structure and 
functional activities (Hutchens, et al. 2012). The protein was modified with several site-
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specific amino acids such as cysteine, methionine, tryptophan, and tyrosine (Lundblad 
2018). LF activities changed due to the type of chemical modifications. For example, 
amidation chemical modification in LF improved antimicrobial function but acylation 
eliminated antimicrobial and antiviral properties (Pan, et al. 2007). The nitration chemical 
modification in LF changes iron-binding properties (Teuwissen, et al. 1973). The focus of 
this work was on protein nitration specific to tyrosine (Tyr) residues. Protein nitration is 
an important tyrosine modification because it is linked to oxidative stress, inflammation, 
aging, and many other diseases (Ogino, et al. 2007; Andreadis, et al. 2003; Tsang, et 
al. 2009; Elahi, et al. 2009; Yeo, et al. 2008). A study showed a reduction in iron 
binding of LF after mutation via converted tyrosine residues in both binding sites 
(Tyr-93, Tyr-193, Tyr-436, and Tyr-529) to alanine residues (Ward, et al. 1996). 
1.6  Analytical techniques to characterize protein nitration   
Modification of Tyr to NTyr can play an important role in the physiological 
system, and the ability to detect and quantify the modified residues can be 
impactful for a number of medically-relevant research endeavors. For example, 
Ischiropoulos reviewed several methods to determine the NTyr concentration in 
diseased samples of human and animal tissue (Ischiropoulos 1998). NTyr has been 
quantified using Western blot (WB) (Hinson, et al. 2000), enzyme-linked 
immunosorbent assay (ELISA) (ter Steege, et al. 1998), high-performance liquid 
chromatography (HPLC) (Crow, et al. 1995), and gas chromatography paired with 
mass spectrometry (GC-MS) (Dalle‐Donne, et al . 2006)  techniques. Tandem mass 
spectrometric (MS/MS) analysis is the most sensitive for detecting low 
concentrations of NTyr and was used to investigate the relationship of nitrated 
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proteins to many diseases, but requires very high up-front cost (ca. $300k to 
$1,000k) and high maintenance costs (Yeo, et al. 2008; Reinmuth-Selzle, et al. 
2014). To overcome some of the limitations presented by MS analysis, many 
studies now substantiate that ELISA can be applied to selectively detect  
nitrotyrosine within a sample (Baker, et al. 2000). 
1.7  Nitration inhibitor  
Through aging and disease, the concentration of ONOO- can be increased 
dramatically and can both alter and impair biological function via nitration reaction. It is 
important to maintain the protein structure by preventing nitration reaction using nitration 
inhibitors.  
There are several nitration inhibitors such as glutathione (GSH) which acts by 
reacting the thiol group with peroxynitrite to prevent nitration (Sies, et al. 1997). 
Hydroxycinnamates acts to protect Tyr from nitration by preventing the electron transfer 
reaction (Pannala, et al. 1998), polyhydroxyphenols by scavenging hydroxyl radical (OH) 
(Chung, et al. 1998), selenocystine, selenomethionine and ebselen by a catalytic cycle to 
reduce peroxynitrite to nitrite (NO2-) (Sies, et al. 1996), and ergothioneine (Ergo) by by 
scavenging ONOO- (Aruoma, et al. 1997). The study showed that Ergo is more effective 
as antioxidant activity towards peroxynitrite radical than other antioxidants for example; 
80% higher than GSH or Trolox C and 25% higher than uric acids by protecting Tyr 
residues from peroxynitrite (Aruoma, et al. 1997; Franzoni, et al. 2006a). 
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1.8 Lactoferrin and health 
1.8.1 The effect of peroxynitrite in eye  
The presence of ONOO- in the eye is generated from over-production of .NO and 
O2.- in tissue and that was caused by physiological and pathological conditions (Allen, et 
al. 1998). For example, an in vitro study showed the effect of inflammation, which 
increased the production of nitric oxide synthase (NOS) in tear fluid and on ocular 
surface tissues, causing damage to the ocular surface.  In that study the concentration of 
NOS in tears was 1.5-5 µM and  5-110 µM in aqueous humour (Park, et al. 2001). The 
oxidative stress markers nitrotyrosine, as a marker for nitric oxide, and malondialdehyde, 
as a marker for lipid peroxidation, were detected in human corneal disease and showed a 
significant relation of oxidative damage to corneal disease. In Figure 1 at (Buddi, et al. 
2002) shows the possible pathways of oxidative stress markers which is produced by 
endothelial nitric oxide (eNOS) or inducible nitric oxide( iNOS)for protein nitration and 
reactive oxygen species for lipid peroxidation (Buddi, et al. 2002). 
1.8.2 The effect of protein nitration in ocular surfaces 
Ocular surfaces have been studied after being directly exposed to oxidative stress 
via environmental conditions and air pollution (Wakamatsu, et al. 2008). An association 
exists between traffic-borne air pollution and ocular diseases (Novaes, et al. 2007; 
Torricelli, et al. 2014). Increased NO2 concentration from vehicle pollution is 
linked to an increase of the inflammatory response of ocular surfaces (Novaes, et 
al. 2010b). Also, oxidative stress affects the ocular health endogenously through 
diseases caused by inflammation (Bosch-Morell, et al. 2002; Chiou 2001). Protein 
tyrosine nitration occurs by tetranitromethane or peroxynitrite (Nakaki, et al. 1999). This 
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nitration happens by the addition of a nitro group in the phenolic ring of the tyrosine 
molecule. Protein tyrosine nitration produced NTyr, 6-nitrotryptophan, and 3,3’-
dityrosine (Thiagarajan, et al. 2004). The NTyr is used a biomarker for several diseases 
such as asthma, hypertension, sickle cell disease and dry eye disease (Greenacre, et al. 
2001). There is only one study that has been done for lactoferrin nitration. This study, by 
Teuwissen et al. showed changes in LF iron-binding properties during the nitration 
process (Teuwissen, et al. 1973).  
1.8.3 Lactoferrin and disease  
Lactoferrin associated with many diseases such as diabetes (Moreno-Navarrete, et 
al. 2009), Crohn's (Sipponen, et al. 2008), neurodegenerative diseases  (Grau Armin, et 
al. 2001), and dry eye diseases (Ohashi, et al. 2003). Lactoferrin is important and 
widespread within mammalian bodily fluid, and our interest is to investigate it in relation 
to the ocular surface. The motivation of nitrated lactoferrin in our research relates to 
ocular disease due to the lack of study in this area. It is important to us to understand the 
role of lactoferrin in ocular surface and the related ocular diseases.  
1.8.4 Lactoferrin role in tears  
The tear film is a thin layer of fluid that covers and protects the ocular surface. 
Tears work as a carrier and excretory system for nutrients and metabolic products from 
corneal tissue (Tiffany 2003; Brock 1995). The ocular surfaces is covered in three layers: 
outer lipids (hydrophobic barrier), middle aqueous (physiological barrier such as 
electrolytes and proteins), and inner mucin (hydrophilic barrier) (Tiffany 2003). The 
thicknesses of the tear film ranges depend to each layer as the follows: 0.1–0.2 µm for 
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lipid, 7 to 8 µm for aqueous, and 30 µm for mucin layers (Johnson, et al. 2004; Walcott 
1998).  
The aqueous layer is an important film layer to the ocular health because it 
contains many components that protect the ocular surface. It contains electrolytes, 
vitamins, hormones, enzymes, immunoglobulins, and protein (Johnson, et al. 2004). 
Proteins in the tear are important to maintain ocular surface health and the changes in this 
protein composition will affect ocular health (Zhou, et al. 2006). Proteins in the tear are 
secreted mainly by the lacrimal gland (Prabha 2014). The tear has a high protein 
concentration of 8 µg/µL proteins and more than 60 proteins present, such as lacitin, 
proline rich proteins, lipocalin, lipophilin, lysozyme, and LF (de Souza, et al. 2006; 
Johnson, et al. 2004). LF has been shown to represent 25% of the tear protein 
concentration, making it a biomarker tear proteins for ocular diseases (Kijlstra, et al. 
1983).   
1.8.5 LF role in cornea 
It has been determined that LF is present in human and murine eye tissues such as 
retina, iris, and cornea (Rageh, et al. 2016). LF works as a host defense protein due to 
multifunctional properties, such as its antibacterial and anti-inflammatory abilities, which 
plays an important role to protect ocular surface (Flanagan, et al. 2009).   
1.8.6 The relation between ocular surface health and nitration   
There are two possible ways for the nitration reaction to the human body: 
endogenous and exogenous. The endogenous pathway for nitration reaction via 
peroxynitrite that related to overproduction of nitric oxide (NO) and superoxide (-O2). 
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This increasing showed a relation to eye diseases such as utveitis and myopia (Chiou 
2001). Also,  review paper showed  NO affect many part of the eye and caused diseases 
(Becquet, et al. 1997). 
One exogenous pathway by which nitration reaction can occur is via reaction with 
reactive pollutant gases formed in urban atmospheres. The ocular surface can be directly 
exposed to gas-phase pollutants, which can then lead to certain medical conditions 
including various diseases. Previous studies have shown that long-term or acute exposure 
air pollution from traffic or industrial sources can cause ocular surface dysfunction and 
changes in tear film stability (Novaes, et al. 2010a; Torricelli, et al. 2013). Torricelli et al. 
(2011) presented a review discussing that the influence of long term exposure to outdoor 
air pollution such as nitrogen dioxide (NO2), ozone (O3), carbon monoxide (CO), and 
particulate matter (PM2.5) can lead to ocular surface alterations (Torricelli, et al. 2011). 
One study showed that a healthy worker who is exposed to traffic air pollution that 
contains a high level of NO2 (>100 µg/m3 equivalent to 48 ppb) and PM2.5 (40 µg/m3) 
showed ocular surface irregularity and reduction in tear film osmolality (Torricelli, et al. 
2014). All these studies tested the changes of the ocular surface using qualitative methods 
such as tear breakup time, the Schirmer test, and vital staining test. The investigation of 
the changes of the ocular surface components needs more consideration to understand the 
reason behind the observed irregularities.  
1.9 Motivation  
Protein nitration is a type of chemical modification that can be related to allergies, 
respiratory distress, and ocular disease in humans. Environmental exposure to air 
pollutants in urban areas can not only cause physical damage to non-living surfaces, 
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plants, and animals, but can also initiate damage to the ocular surface because it is in 
direct contact with reactive atmospheric species such as nitrogen oxide and ozone. The 
effects of this interaction are not known but could reasonably include changes in 
lactoferrin, an ocular protein whose reduced concentration correlates with many ocular 
diseases. The air pollution contains a mixture of chemical components that effect human 
health via protein modifications such as nitration and oxidation reactions. These 
modifications changed the natural characteristics of human tissue and caused diseases. 
There are many studies of air pollution and human diseases but few focuses on ocular 
surface disease. In order to promote this investigation, it is important to understand the 
connection between the ocular surface marker and the effects of modifications caused by 
air pollution. This research may help in the investigation and treatment of lactoferrin-
related diseases such as dry eye diseases.  
1.10 Hypotheses 
Several linked hypotheses were investigated.  
- The nitration modification can attenuate antibacterial activity of lactoferrin. 
Ergothioneine, an inhibitor of nitration, may be useful as a therapeutic treatment against 
NLF-related disease. 
- Lactoferrin is an important protein in tear film function, and nitration of LF may 
actively  It may be possible to develop a quantitative technique, such as sandwich ELISA, 
that is both sensitive and selective enough to quantify nitrated lactoferrin.   
- A potential nitration inhibitor, ergothioneine, might also be effective in treatments of 
dry eye disease.  
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1.11 Objectives  
To evaluate this modification, this study was designed to first investigate nitration 
reactions in the lab using two reactions as proxies of endogenous and exogenous models. 
Reaction products were identified and characterized using spectroscopic analysis. Next, a 
binding assay was developed in lab to quantify the nitration product. This assay is a novel 
and unique detection method which has eventual potential application in the clinical 
laboratory. Next, LF protein function was tested for biological changes using 
antibacterial and circular dichroism assays. These biochemical functions were used to 
evaluate the protein changes after nitration. Finally, an inhibitor molecule was applied to 
the nitration reaction to investigate the reduction of the nitration process. This 
investigation was used to work toward a possible anti-inflammatory treatment to protect 
the protein from the nitration affect. 
Our research focused on the nitration role in lactoferrin and how that affects the 
bioactivities which can be useful in the clinical investigation for future research of ocular 
health in urban areas.  
1.12 Research Aims 
This dissertation describes three interrelated projects: Chapter 2 discusses the 
development of a novel sandwich ELISA to quantify nitrotyrosine in nitrated lactoferrin 
samples. Chapter 3 discusses changes in the antibacterial activity of nitrated lactoferrin. 
Chapter 4 discusses the effect of Ergo in protecting lactoferrin from the nitration process. 
The outcome of these studies hopes to provide value toward understanding the effects of 









Chapter two: Development of a sandwich ELISA with potential for selective 
quantification of human lactoferrin protein nitrated through disease or 
environmental exposure 
Peer-reviewed and published in the following form, with only minor textual modification: 
Anal Bioanal Chem. 2018 Feb;410(4):1389-1396. doi: 10.1007/s00216-017-0779-7. 
Electronic publication date: December 6, 2017. 
2.1 Abstract 
Lactoferrin (LF) is an important multifunctional protein that comprises a large 
fraction of the protein mass in certain human fluids and tissues, and its concentration is 
often used to assess health and disease. LF can be nitrated by multiple routes, leading to 
changes in protein structure, and nitrated proteins can negatively impact physiological 
health via nitrosative stress. Despite an awareness of the detrimental effects of nitrated 
proteins and the importance of LF within the body, cost-effective methods for detecting 
and quantifying nitrated lactoferrin (NLF) are lacking. We developed a procedure to 
selectively quantify NLF using sandwich enzyme-linked immunosorbent assay (ELISA), 
utilizing a polyclonal anti-LF capture antibody paired with a monoclonal anti-
nitrotyrosine detector antibody. The assay was applied to quantify NLF in samples of 
pure LF nitrated via two separate reactions at molar ratios of excess nitrating agent to the 
total number of tyrosine residues between 10/1 and 100/1. Tetranitromethane (TNM) was 
used as a laboratory surrogate for an environmental pathway selective for production of 
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3-nitrotyrosine, and sodium peroxynitrite (ONOO-) was used as a surrogate for an 
endogenous nitration pathway. UV-vis spectroscopy (increased absorbance at 350 nm) 
and fluorescence spectroscopy (emission decreased by >96%) for each reaction indicates 
the production of NLF. A lower limit of NLF detection using the ELISA method 
introduced here was calculated to be 0.065 µg mL-1, which will enable the detection of 
human-physiologically relevant concentrations of NLF. Our approach provides a 
relatively inexpensive and practical way to assess NLF in a variety of systems. 
2.2 Introduction   
 Lactoferrin (LF) is an iron-binding protein that is present in many tissues 
and fluids of the human body and is critical to diverse physiological functions 
(Kanyshkova, et al. 2001). LF exists in various exocrine fluids such as tears, milk, 
and saliva (Vorland 1999; Kijlstra, et al. 1983) and possesses significant 
antifungal, antiviral, and antibacterial functions within the body (Jenssen, et al. 
2009). Lactoferrin has a molecular weight of ca. 80 kDa and contains 703 amino 
acids, including 20 tyrosine residues and two globular lobes linked by an α-helix 
(Lönnerdal, et al. 1995). Each lobe contains two tyrosine residues at the center of 
its structure that participate with other amino acids as one iron binding site 
(Vorland 1999). The concentration of LF in human tissues has not been well-
studied, but is critical for physiological function (González-Chávez, et al. 2009).  
Chemical modification of proteins like LF can also play important roles in 
controlling protein function. Free radicals such as reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) are broadly important within the human body 
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and as exogenous agents because they can lead to modifications that can affect 
protein function and harm the living system (Valko, et al. 2007). Specifically, the 
presence of nitrotyrosine-modified proteins is associated with many 
neurodegenerative, cardiovascular, respiratory, and ocular surface diseases (Yeo, 
et al. 2008). One mechanism by which tyrosine nitration may affect physiology is 
through protein denaturation leading to an irreversible loss of function (Gow, et al. 
1996). Damage to tissue can also induce an increase in NO synthesis, releasing 
more peroxynitrite and leading to further increases in protein nitration (Pfeiffer, et 
al. 2001). Thus, 3-nitrotyrosine (NTyr) can be used as a biomarker for nitrosative 
stress diseases in body fluids such as blood, urine, and tears (Dalle‐Donne, et al . 
2005). Many ROS and RNS exist within the human body and contribute to the 
pathology of a variety of medical conditions. Peroxynitrite, in particular, has been 
shown to induce nitration of tyrosine (Tyr) residues as well as those of several 
other amino acids (Beckman 1996). One important pathway by which ONOO- 
induces tyrosine nitration involves an electron oxidation reaction of the phenolic 
ring, which forms an intermediate radical at the 3-position of the ring, followed by 
combination with NO2 to generate NTyr, as summarized in Figure 2. 1 (Radi 
2013).  
Significant effort has gone into the investigation of ROS in the atmosphere 
and it is effects on human health. By comparison, relatively little study has been 
invested in what parallel role RNS may play in the same environmental systems 
(Wiseman, et al. 1996). One source of exogenous RNS is free radicals and reactive 
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gases in the air that are emitted, directly or indirectly, by combustion sources and 
are higher in polluted, urban areas (Reinmuth-Selzle, et al. 2017). Contact between 
adjuvants such as pollutant gases and proteins on the surfaces or fluids of the skin, 
eyes, mucous membranes, and lungs can provide an important pathway of 
chemical reactivity (Lakey, et al. 2016), and exposure to nitrogen oxide gases 
influences many cardiovascular, respiratory, and ocular surface diseases (Patel, et 
al. 1999). Investigating the amount of nitrated proteins in urban road dust indicates 
that proteins on the surface of pollen and other biological particles can be nitrated 
in urban air and thus could influence human health (Franze, et al. 2005).   
In the atmosphere, tyrosine nitration is thought to proceed through a 
mechanism by which O3 and NO2 gases selectively produce a 3-NTyr product 
(Franze, et al. 2003; Reinmuth-Selzle, et al. 2014; Kampf, et al. 2015), whereas 
reaction with ONOO- can modify a wider set of amino acid residues, as discussed. 
Tetranitromethane (TNM) is frequently used in the laboratory as a surrogate for 
the heterogeneous O3 and NO2 mechanism, because it also selectively produces the 
3-NTyr product (Franze, et al. 2005; Shuker, et al. 1993). Sokolovsky et al. 
illustrated the TNM mechanism that inserts a nitro group into the aromatic ring 
specifically at the ortho position to produce 3-NTyr as in Figure 2. 2 (Sokolovsky, 
et al. 1966). It is important to note that both Figure 1 and 2 lead to nitrated tyrosine 
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Figure 2. 1 Production of NTyr from Tyr reacting with peroxynitrite. Reaction 











+ + C(NO2)3- + 2H+C(NO2)4
Tyr 3-NTyr Nitroformate  
Figure 2. 2 Production of NTyr from Tyr reacting with tetranitromethane. 
 A number of laboratory techniques have been utilized to detect and quantify 
NTyr, especially for medically-relevant research endeavors (Crow, et al. 1995). 
Among those, tandem mass spectrometric (MS/MS) analysis is the most sensitive 
for detecting low concentrations of NTyr and has been used to investigate the 
relationship of nitrated proteins to many diseases, but requires very high up-front 
(ca. $300k to $1,000k) and maintenance costs (Yeo, et al. 2008; Reinmuth-Selzle, 
et al. 2014). To overcome some of the limitations presented by MS analysis, many 
studies now show that enzyme-linked immunosorbent assay (ELISA) can be 
applied to selectively detect and quantify low concentrations of nitrotyrosine 
within a sample (e. g.Baker, et al. 2009). ELISA has been used to quantify LF 
concentration in milk, plasma, and tear fluid (Kijlstra, et al. 1983) as well as NTyr 
in plasma and urine (Jamshad, et al. 1998). Only once has the detection of 
lactoferrin nitration been reported directly, however. Teuwissen et al. used a 
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combination of iron binding capacity and optical rotator dispersion to detect 
changing tyrosine properties upon nitration of LF (Teuwissen, et al. 1973). 
Despite the importance of LF and nitrated proteins within the human system 
and as biomarkers for many diseases, very little has been reported on chemical 
modifications of LF. This is due in part to the challenges to inexpensively and 
selectively quantify nitrated lactoferrin (NLF). We summarize two independent 
methodologies to nitrate LF via aqueous reaction, utilizing TNM as a surrogate for 
exogenous atmospheric nitration and ONOO- as a model of endogenous 
physiological nitration pathway. Spectrophotometry was utilized as a method to 
show modifications to the protein. Further, we describe herein the development 
and optimization of a novel sandwich ELISA technique to selectively quantify 
NTyr in lactoferrin after nitration by each pathway. Using the reported ELISA 
protocol, we anticipate the ability to selectively quantify NLF at physiologically 
relevant concentrations, nitrated by either endogenous or exogenous pathways in 
human tissue and fluid samples, thus providing researchers without access to 
expensive instrumentation an accurate and effective way to measure NLF. 
2.3 Experimental 
2.3.1 Endogenous nitration of LF using sodium peroxynitrite 
 The peroxynitrite reaction was prepared following the method reported by 
Selzle et al. (Selzle, et al. 2013), replacing Bet v 1 with LF and adjusting for 
differences in the number of tyrosine residues between the two proteins. According 
to this procedure, 200 µL aliquots of 5.0 mg mL-1 LF in aqueous solution was 
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pipetted into 2.5 mL glass vials. PBS buffer, followed by NaONOO, was then 
added, and reaction solutions were stirred on ice for 2 hours. NaONOO was added 
in different amounts corresponding to peroxynitrite to tyrosine (ONOO-/Tyr) molar 
ratios of 10/1, 20/1, 30/1, 40/1, 60/1, 80/1, and 100/1. PBS buffer was added to a 
total volume of 1000 µL for each solution at NLF concentration of 1.0 mg mL-1. 
Previous work showed that concentrations of LF higher than this produced lower 
nitration reaction efficiency (Vincent, et al. 1970). Details regarding materials and 
reagents are listed in the supplemental material. 
2.3.2 Exogenous nitration of LF using tetranitromethane 
 The tetranitromethane nitration reaction was prepared following the method 
reported by Teuwissen et al. (Teuwissen, et al. 1973). Similar to the above 
procedure, 200 µL aliquots of 5.0 mg mL-1 LF in aqueous solution was combined 
with Tris buffer, followed by 200 µL of ethanol and TNM, in 2.5 mL glass vials., 
TNM was added in amounts  corresponding to tetranitromethane to tyrosine 
(TNM/Tyr) molar ratios between 10/1 and 100/1. Mixtures were stirred at room 
temperature (RT) for 4 hours. Tris buffer was added to a total volume of 1000 µL 
at NLF concentration of 1.0 mg mL-1.  
In all cases described below, NLF used as standard reference material for ELISA 
protocols was produced using the 40/1 molar ratio of TNM/Tyr reaction described 
here. Also in all cases, LF and NLF concentrations are reported as ±5%, which was 
limited by the precision of LF mass amount in the originally purchased vial. 
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2.3.3 Spectroscopic analysis 
 For all spectroscopic analyses, quartz cuvettes were used, and LF and NLF 
samples were diluted in PBS buffer. Dilution calculations were performed by 
taking the molecular mass of LF, irrespective of mass changes due to nitration. 
UV-vis absorption spectroscopy was performed using a Cary BIO 100 
spectrophotometer. Absorption spectra were acquired in 2 nm steps from 250 to 
500 nm. 
Fluorescence spectroscopy was conducted using a Varian Cary Eclipse 
Fluorescence G9800A spectrophotometer equipped with a xenon lamp as 
excitation source. The excitation wavelength was stepped every 2 nm, and 
fluorescence emission spectra were acquired from 200 to 500 nm at 2 nm 
resolution.  
2.3.4 Direct ELISA for characterization of nitrotyrosine antibody 
 Direct ELISA was used to determine the optimal dilution factor of the detector 
antibody that was later used in the sandwich ELISA procedure. Nitrated bovine serum 
albumin (NBSA, 6/1 TNM/Tyr) was serially diluted into carbonate buffer producing five 
concentrations of NBSA. Microwells were coated in triplicate with each NBSA solution, 
and pure carbonate buffer was used as a blank. The plate was covered, sealed with sterile 
tape, and incubated at 4°C for 17 hours overnight. After incubation, the wells were 
washed in duplicate by adding 200 µL of PBST (PBS with 0.05% Tween). Each 
subsequent incubation step also followed a similar process of sealing, continuous shaking 
during the incubation period using a rocking platform (UltraRocker, BIO-RAD), and then 
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duplicate washing with PBST. After washing, wells were blocked with 200 µL of 
blocking buffer (5% BSA in PBS) and incubated at RT for 2 hours. After washing, mouse 
monoclonal to nitrotyrosine biotinylated antibody (anti-NTyr) was diluted in blocking 
buffer in four different dilution ratios between 1:100 and 1:1000). 50 µL of each dilution 
was added in triplicate and incubated for 1 hour at RT, thus utilizing 12 wells (four 
dilution ratios X triplicate measurements) for each NBSA concentration. Next, 50 µL of 
streptavidin-HRP (diluted 1:10,000 in blocking buffer) was added before incubation at 
RT for 1 hour. Each plate was developed by adding 100 µL of TMB substrate to each 
well and incubating at RT until the color turned blue (ca. 10 min). The substrate reaction 
was stopped after 10 minutes by adding 100 µL of 0.5 N aqueous sulfuric acid, 
prompting the solution to turn yellow. The optical absorbance of each well was measured 
using a microwell plate reader (Tecan Infinite, M1000 PRO). Following standard 
procedures (Rajasekariah, et al. 2003), the absorbance of the substrate background at 620 
nm (blue) was subtracted from the absorbance at 450 nm (yellow) to produce the 
absorbance values reported on all plots. 
2.3.5 Sandwich ELISA for quantification of NLF 
 For the sandwich ELISA procedure introduced here, goat polyclonal to 
lactoferrin non-conjugated antibody (anti-LF) was used as the capture antibody, 
and mouse monoclonal to nitrotyrosine biotinylated antibody (anti-NTyr) was used 
as the detector antibody (clone number CC.22.8C7.3). Details regarding the choice 
and dilution ratio of antibodies are outlined in the supplemental material (Section 
A. 6). Microwells were coated with 50 µL of diluted capture antibody and 
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incubated at 4°C overnight. The plate was then washed and blocked as described 
above. NLF was serially diluted into blocking buffer producing NLF solutions at 
eight concentrations. After a second washing step, 50 µL of each of the eight NLF 
solutions was added in triplicate to the plate and incubated at RT for 1 hour. 
Blocking buffer was used for blank measurements. 50 µL of the detector antibody, 
diluted in blocking buffer to a ratio of 1:100, was then added, and the plate was 
incubated with shaking at RT for 1 hour. Streptavidin-HRP and TMB were added 
following the ELISA protocol, as described above. 
2.3.6 Data analysis 
 Data points are shown here as mean ± sample standard deviation (s). 
Statistical analysis was analyzed using Igor Pro 7 (Wavemetrics, Inc.; Oregon, 
USA). The experiments were carried out in triplicate and the results were subjected 
to t-tests to provide a measure of significance. 
2.4 Results and Discussion 
2.4.1 Detection of NLF using absorption spectroscopy  
 After nitration of LF via the two pathways (TNM and ONOO-), nitration 
products were detected using UV-vis absorption spectroscopy. Figure 2. 3 shows 
absorption spectra of LF and NLF nitrated separately by ONOO- (NLFONOO-) and 
TNM (NLFTNM) reactions. Absorption measurements at 280 nm are commonly 
used as a general tool for the detection of proteins that contain at least one of the 
three aromatic amino acids Phe, Tyr, or Trp. The spectrum of LF (Figure 2. 3, 
black trace) shows one band at 280 nm, which represents absorption by a 
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combination of these aromatic amino acids. The absorption spectrum of NLFTNM 
(Figure 2. 3, red trace) shows a peak at 350 nm, consistent with the peak location 
of nitrated tyrosine (Riordan, et al. 1966). An additional product of the reaction is 
nitroformate, which also absorbs at 350 nm (Sokolovsky, et al. 1970). As a result, 
the reaction mixture was purified (see supplemental section A. 3), and the 
absorption spectra were compared before and after purification to verify the 
presence of NLF without interference. Both spectra show the peak at 350 nm, 
qualitatively verifying the presence of the product. Quantitative comparison is 
more complicated due to uncertainties in concentration introduced by dilution 
during purification. 
The absorption spectrum of NLFONOO- (Figure 2. 3, blue trace) shows a NLF 
peak at 350 nm as well as a double-humped peak at 280 from unreacted Phe, Tyr, 
and Trp in the protein. The NLFONOO- product was not purified before 
spectroscopic analysis, because secondary reaction products and degradation by-
products of ONOO- do not overlap with the 350 nm peak (Jankowski, et al. 1999). 
As a result, the quantity of NLFONOO- product is unambiguous here. In the case of 
the ONOO- reaction, modification of the protein is not limited to tyrosine, and the 
absorption spectrum of the nitrated product can be broadened by nitration of Phe, 
Tyr, and Trp residues (ter Steege, et al. 1998). Further, the relative tyrosine 
nitration yield from ONOO- is reduced compared to the TNM reaction, because the 
ratio of ONOO- to the sum of all nitrate-able amino acids is lower than the ratio of 




Figure 2. 3 Absorption spectra of lactoferrin and nitration products from two 
nitration reactions (1 mg mL-1 each). Each NLF product produced at 1/40 molar 
ratio of Tyr to respective nitrating reagent. NLFTNM product shown in purified 
form to remove interference from nitroformate by-product. 
2.4.2 Detection of NLF using fluorescence spectroscopy  
 Fluorescence spectroscopy has also been frequently used to detect protein 
modifications, due to changes that can take place in protein molecular 
conformation (Kronman, et al. 1971). Tyr exhibits among the highest fluorescence 
quantum yield of all amino acids, and it is the primary source of fluorescence in 
proteins without Trp. When situated sufficiently close (ca. <5 nm) to Trp within a 
protein structure, however, Tyr experiences efficient resonance energy transfer to 
Trp and so is often not responsible for observed fluorescence (Lakowicz 2013; 
Pöhlker, et al. 2012). LF exhibits relatively strong fluorescence emission because it 
contains a large number of aromatic amino acids, including Phe (32), Tyr (20), and 
Trp (10) (Bläckberg, et al. 1980). Fluorescence from nitrated proteins has 
previously been shown to reduce total intensity from native proteins and can thus 
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be used as a quantitative measure of nitration (Crow, et al. 1996; De Filippis, et al. 
2006). 
Figure 2. 4 shows fluorescence excitation emission matrices for native LF 
as well as for NLFTNM and NLFONOO-. In the presence of nitrating agents, the 
addition of a nitro group (NO2) onto Tyr decreases the pKa of the hydroxyl group 
in the phenolic ring. As a result, the substitution of a large hydrophobic NO2 group 
sterically hinders the tyrosine structure and can cause conformational changes to 
the protein (Radi 2013). This reduces the absorbance intensity due to the 
unmodified protein and also the intensity of the fluorescence emission.  
LF shows strong emission centered at λEm 330 nm for two excitation bands 
at λEx 224 and 280 nm due to a large number of Tyr and Trp residues, consistent 
with previous studies (Meyer, et al. 2015). Both nitrated products show 
dramatically decreased emission intensity (Figure 2. 4 d; NLFTNM, 98% decrease 
and NLFONOO-, 96% decrease) due to the addition of NO2 groups to LF, 
qualitatively matching observations for nitrotyrosine reported by Crow et al. 
(Crow, et al. 1996). The emission intensity of NLFTNM is reduced by a greater 




Figure 2. 4 Fluorescence EEMs for native LF (a), NLFTNM (b), and NLFONOO- 
(c). Diagonal lines indicate elastic scattering from excitation source. EEM color 
scale indicates emission intensity, in logarithmically scaled arbitrary units (arb.). 
Peak emission intensity at λEX280 nm for each panel summarized in panel (d). 
2.4.3 Design of sandwich ELISA assay for quantification of NLF 
The sandwich ELISA developed here was designed to detect NTyr bound to 
LF protein in NLF samples. The assay first utilizes polyclonal anti-LF capture 
antibodies to bind LF proteins. This antibody recognizes a specific sequence of 13 
amino acids in the LF protein (see supplemental Section A. 4) (abcam 2017). 
Second, monoclonal anti-NTyr detector antibodies are used to attach to specific 
NTyr residues bound on captured NLF proteins. For the capture process, 
polyclonal antibodies were used to enhance the probability of binding, given the 
many sites at which nitration could affect LF binding, whereas monoclonal 
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antibodies were used as detector antibodies to selectively enhance the assay’s 
sensitivity (Fig. A. 2). The scheme is conceptually similar to the sandwich ELISA 
protocol introduced by Franze et al., which detects NTyr in nitrated birch pollen 
protein (Nitro-(3)-Bet v 1) and used rabbit polyclonal anti-Bet v 1 protein as 
capture and mouse monoclonal anti-NTyr as detector antibodies (Franze, et al. 
2003). The detector antibody chosen here has been used in many immunoassay 
applications (Ferrante, et al. 1997) because it has low cross-reactivity (Chou, et al. 
1996) and high sensitivity (Aggarwal, et al. 2011). See supplemental Section A. 6 
and Figures A. 1-A. 2 for additional details about assay development.  
2.4.4 Development of sandwich ELISA 
 In order to develop the modified sandwich ELISA for detection of NLF, 
each of the two antibodies was tested separately using direct ELISA and combined 
into a single sandwich ELISA. As a first step, direct ELISA was used to determine 
the optimal buffer dilution ratio of NBSA antigen to the nitrotyrosine biotinylated 
antibody (analogous to supplemental Fig. A. 3, without the initial capture antibody 
step). Four dilutions ratios from 1:100 to 1:1000 were investigated. The 1:100 
dilution exhibited the highest binding sensitivity, shown as the steepest slope in 




Figure 2. 5 Optimization of detector antibody using direct ELISA. The optical 
absorbance shows ELISA well absorbance at four dilution factors (anti-NTyr into 
blocking buffer). Data points are mean values ± s, n= 2. Traces are linear fits. 
As a second step, the full sandwich ELISA was used to optimize the 
dilution of capture antibody (anti-LF). The 1:1000 (v/v) dilution of capture 
antibody was selected, because it exhibited binding sensitive similar to the 1:250 
(v/v) dilution, but requires less antibody volume (Fig. A. 4). Using the higher 
dilution thus achieves sensitive detection at lower cost.  
A calibration curve of optical absorption versus NLF concentration was 
developed as the final detection step of the sandwich ELISA (Figure 2. 6). A range 
of molar ratios between 10/1 and 100/1 were investigated (Fig. A.5-A.6), and the 
40/1 molar ratio of TNM/Tyr was chosen as the protein standard. Sandwich ELISA 
results show a decrease in detected NLF concentration produced at nitration ratios 
higher than 40/1. The reason for this could be due to a reduction in antibody 
binding due to LF changes at capture antibody binding sites or as a result of 
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denaturation of LF protein. Results published by Teuwissen et al. also show 
NLFTNM properties peaking at a 40/1 molar ratio (Teuwissen, et al. 1973).  
The limit of detection (LOD) for the newly developed assay was calculated 
by two separate methods by measuring the mean + three times the sample standard 
deviation of a set of three absorbance measurements following sandwich ELISA. 
LODLF was calculated as 0.032 absorbance units (AU) by replacing native LF for 
NLF as the antigen in the assay, and LODblank was calculated as 0.022 AU by 
withholding any antigen from the assay. A minimum detectable NLF concentration 
of 0.065 µg mL-1 was calculated as 3 sLF/m, where sLF is the standard deviation of 
the blank measurement and m is the slope of NLF calibration curve. Using the 
responses from the sandwich ELISA (Figure 2. 6), t-tests showed the NLF 
measurement to be statistically different (p-value < 0.01) from the LF 
measurement at all antigen concentrations measured (minimum 0.18 µg mL-1; see 




Figure 2. 6 Sandwich ELISA calibration curve. 
 for NLF (40/1 TNM/Tyr) and LF in several concentrations (0.18, 0.37, 0.75, 1.5, 
3.0, 6.0, 12.0, and 25.0 µg mL-1). Data points are mean values. Vertical error bars 
(black) shown as standard deviation s, n= 4. Linear fit for NLF, R2 = 0.993.  
To confirm the results from the new ELISA protocol, Figure 2.5 shows that 
the molecular absorbance of NLF (black traces) and responses from the sandwich 
ELISA (red bars) each increase with increasing molar ratio of TNM or ONOO- to 
Tyr. Supplemental Figure A.5 shows an extension of the ELISA response to higher 




Figure 2. 7 UV-vis absorbance at 350 nm (black traces; left axes) and ELISA optical 
density at 450 nm (red bars; right axes) of NLF using two different nitration reagents; 
ONOO- (a) and TNM (b). Error bars on ELISA data represent standard deviation of 
measurements from individual wells (a) n = 6, (b) n = 3. 
 NLF samples produced using the TNM reaction were tested in both purified 
and non-purified forms, following procedures outlined above. Absorbance values 
and sandwich ELISA results show no statistical differences, and so all NLFTNM 
data shown here (Figure 2. 6 and Figure 2. 7) are shown without any purification 
(see supplemental material and Fig. A. 7). The ability of the assay to work 
effectively without cleaning the product is important, because it shows that the 
ELISA protocol developed here can be applied broadly to samples extracted from 
tissues and fluids without need to perform additional cleaning steps that can 
increase analysis costs and quantitative uncertainty. In contrast to this, the 
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NLFONOO- samples can degrade over time if produced via the reactions outlined 
above. NLFONOO- samples thus require purification before storage to limit 
agglomeration and protein changes induced by the presence of excess ONOO- 
(Estillore, et al. 2016). 
2.5 Conclusions 
 NLF samples were synthesized using two different nitration reagents in 
varying ratios of molar excess. ONOO- was used as an endogenous model and 
TNM was used as an exogenous model. Both nitrated products were characterized 
by UV-vis and fluorescence spectroscopy, showing dramatic changes upon 
nitration. To quantify the concentration of NLF produced from each reaction, we 
developed a novel sandwich ELISA for the selective detection of NTyr bound 
within NLF antigens. We demonstrate a LODLF of 0.032 AU and a LODblank of 
0.022 AU, translating to a lower limit of detectable NLF concentration of 0.065 µg 
mL-1. An important feature of this sandwich ELISA protocol is that is does not 
require sample purification, meaning that quantitative uncertainty introduced from 
imprecise dilution through washing steps can be avoided. The NLF sandwich 
ELISA introduced here is a novel method that was demonstrated to be applicable 
to the quantification of nitrotyrosine in lactoferrin. LF is the most concentrated 
protein in human tears, representing up to 25% of protein mass, or approximately 
2.2 mg mL-1 (Kijlstra, et al. 1983). The concentration of ONOO- generated in 
inflamed corneal tissue has been shown to be in the approximate range of 3-30 µM 
(Ashki, et al. 2014). NLF has never been quantified in tissue or fluid samples, but 
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if even 30 of every 106 LF molecules (30 ppm) were nitrated by ONOO-, NLF 
concentrations would be above detection limits reported here. Thus, NLF is likely 
to be detectable by this procedure at physiologically relevant concentrations. As a 
result, this assay has important application to the investigation of NLF produced 
through inflammatory pathways in human tear, milk, and ocular tissues samples, 









Chapter three: Nitration reduces antibacterial activity of lactoferrin by changing its 
structural and functional properties  
In preparation for submission for peer review. 
3.1 Abstract 
Protein nitration is an important protein modification that has been correlated with 
both disease and urban air pollution. Here we examine the antibacterial properties of 
lactoferrin (LF) protein, which plays an important role in the biological system as one of 
the most concentrated proteins in several human fluids and tissues. Peroxynitrite (ONOO-
) was used to induce nitration on LF as a mimic of physiologically relevant biochemical 
modification, producing nitrated lactoferrin (NLF). The reaction selectively generates 
nitrotyrosine residues, which are commonly used as biomarker molecules for a number of 
diseases. Our results show that nitration of LF at 10/1 and 40/1 molar ratios was sufficient 
to inhibit all of the antibacterial activity exhibited by native LF. Secondary structural 
changes in the LF protein were assessed using circular dichroism (CD) spectroscopy. 
Spectral changes upon nitration in both unligated and iron-bound cases show a significant 
reduction in alpha-helical properties, suggesting partial protein unfolding. Iron-binding 
capacity of LF also showed reduction after nitration using two separate assays. This study 
is the first to show inhibition of antibacterial properties of NLF, and the observations thus 
represent a possible link to pathways of biochemical modification that take place during 





nitration could play in the immune defense system of the human eye, liver, and other 
organs, biochemical treatments may be explored that could reduce damage directly from 
nitration pathways, and also due to secondary bacterial infections. 
3.2 Introduction 
(Strøm, et al. 2002; Kang, et al. 1996b)(Nuijens, et al. 1996)(Ward, et al. 2002)LF 
is a member of the transferrin family of proteins that binds iron ions (Fe3+) and regulates 
iron levels in the physiological system. Specifically, LF functions as an iron transporter 
and serves important bacteriostatic and anti-viral roles (Farnaud, et al. 2003). The protein 
structure consist of two iron binding sites, each of which can bind with an individual Fe3+ 
ion (Adlerova, et al. 2008). The iron binding site in each lobe consists of four amino acid 
residues: two tyrosine, one aspartic acid, and one histidine. Thus, the protein provides 
four ligands at each binding site: two phenolate oxygen atoms from Tyr, one carboxylate 
oxygen from Asp, and one imidazole nitrogen from His (Baker, et al. 1990). 
LF is widely used as an antibacterial agent against both gram-positive (e.g. 
Streptococcus faecalis) and gram-negative bacteria (e.g. Escherichia coli), though gram-
negative bacteria are more resistant than gram-positive bacteria due to the presence of 
outer membranes (Rt D. Ellison, et al. 1988). LF serves antibacterial functions by two 
separate mechanisms. As a bacteriostatic agent, LF serves to limit bacterial growth by 
binding Fe3+, thereby reducing the concentration of available iron required for growth. As 
a bactericidal agent, LF can bind to the surface of bacterial cells, releasing 





cell (Rt D. Ellison, et al. 1988). It is important to note that due to the iron-binding 
properties of LF, iron-bound LF shows no antibacterial activity (Dionysius, et al. 1993). 
As a result of the interactions between the protein and either Fe3+ or the bacterial 
surface, chemical modifications at certain amino acid residues of the LF structure are 
likely to impact the protein’s physiological functions. For example, modification of LF 
by replacing histidine with glutamic acid, cysteine, tyrosine, or methionine, was shown to 
reduce the iron-binding function of the protein (Nicholson, et al. 1997). Nitration of 
tyrosine resides bound within proteins has also been shown to be possible via several 
mechanisms and has been linked to a variety of deleterious health effects (Radi 2013). 
Peroxynitrite is one of the most effective endogenous protein nitrating agents, inducing 
changes in protein structure and function, and has been implicated as a stressor related 
e.g. to cardiovascular disease (Thiagarajan, et al. 2004; Saxena, et al. 2003). In particular, 
3-nitrotyrosine has been used as a marker for inflammation and nitrosative stress 
(Eleuteri, et al. 2009) and is also selectively produced by reaction with certain 
environmental pollutants (Shiraiwa, et al. 2017; Franze, et al. 2005).  
Despite the depth of literature that has focused on lactoferrin and the nitration of 
other human proteins, the effect of nitration on critical bioactivity functions of LF has not 
been studied. Here the study presents experimental results that show for the first time that 
peroxynitrite-induced nitration of LF reduces the antibacterial properties of the protein. 
This nitration presents an overview of changes in LF secondary structure as measured by 





LF nitration. This study also suggests possible links between changes in the secondary 
protein structure and observations about reduced antibacterial activity. 
3.3 Experimental  
3.3.1 Materials 
Human milk lactoferrin (LF; L0520), sodium phosphate dibasic (RES20908-
A702X), potassium chloride (P9333), sodium chloride (S9625), potassium phosphate 
monobasic (P5655), Iron(III) chloride hexahydrate (FeCl3.6H2O; 236489), Nitrilotriacetic 
acid (NTA; N9877), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020), 
Tryptic Soya broth (TSB; 22092), Chloramphenicol antibiotic (CAM; C0378), and 
Tryptic Soya agar (TSA; 22091) were obtained from Sigma Aldrich (USA). Sodium 
peroxynitrite (NaONOO; 516620), Amicon Ultra-0.5 centrifugal filters (30 kDa, 0.5 mL 
volume; UFC503008), and Amicon Ultra-4 centrifugal filters (30 kDa, 4 mL size; 
UFC803024) were obtained from Calbiochem (USA). 100 mm x 15 mm petri dish with 
grip ring (sterile; 229692) were obtained from CELLTREAT (USA). Flat-bottom, 96-
microwell plates (untreated; 333-8013-01F) and sterile sealing tape (ST-3095) were 
obtained from Life Science Products (USA). UV, 96-microwell plates with transparent 
flat bottom (3635) were obtained from CORNING (USA). Escherichia coli (E. coli; 
ATCC25922) were obtained from the American Type Culture Collection (USA).  
Buffers and iron solution were prepared as follows: phosphate-buffered (PB; 0.1 
mM sodium phosphate dibasic and 0.5 M sodium phosphate monobasic at pH 7.4), 





phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM sodium chloride at pH 
7.4), Tris-HCl buffer (Tris; 50 mM at pH 4.0, 150 mM sodium chloride ,20 mM sodium 
carbonate and 71.0 mM sodium bicarbonate at pH 7.4), ferric nitrilotriacetic acid 
(Fe(NTA)2) solution (FeCl3.6H2O 4.0 mM and NTA 8.0 mM and 1 N HCl add 2% to 
total solution volume at pH 4.0). Tryptic soya broth and tryptic soy agar were prepared 
following the manufacture instructions. 
3.3.2 Nitration of lactoferrin by alkaline peroxynitrite (ONOO-) 
Samples of nitrated lactoferrin were prepared for the iron-binding assays 
following the procedure described by Alhalwani et al. (Alhalwani, et al. 2018) Briefly, 
the reaction was prepared in 96-microwell UV-plates by adding 100 µL aliquots of 10.0 
mg mL-1 (± 5%) human milk LF in aqueous solution into each well, then adding 
NaONOO to each well in two different amounts (5.66 and 22.73 µL) corresponding to 
peroxynitrite to tyrosine (ONOO-/Tyr) molar ratios of 10/1 and 40/1. The volume of Tris-
HCl buffer added to each solution was matched with the volume of NaONOO added in 
order to make a total volume of 200 µL and a NLF concentration of 5.0 mg mL-1 (± 5%). 
The microwell plate was set on ice for 120 min. The product of nitration reaction was 
purified using a micro-centrifugal filter device (0.5 mL) and rinsed twice with nanopure 
water.  
Samples of NLF were prepared for the antibacterial assay, following above 
procedure, but replacing PBS buffer for Tris-HCl buffer. The buffer used for each assay 





properly dissolve Fe3+, whereas PBS was used for the antibacterial assay as standard 
physiological buffer mimic that is non-toxic to the bacterial cells.   
3.3.3 Broth antibiotic susceptibility assay to test antibacterial function 
The protocol used here generally followed procedures outlined by Wiegand et al. 
for the minimum inhibitory concentration assay, with some modifications (Wiegand, et 
al. 2008). Briefly, E. coli was prepared by suspending the entire volume of the purchased 
bacterial powder in 5 mL of broth. After 24 hrs of incubation, 1 mL of this broth was 
mixed 1:1 with glycerol to produce the glycerol stock of E. coli that was stored up to long 
term for many years at ca. -80oC. When ready, a 1 µL aliquot of the glycerol stock of 
bacteria was incubated in TSA plates at 37ºC for 24 hrs. Subsequently, three to five 
separate colonies from each plate were selected and transferred into 4 mL TSB and 
incubated at 37ºC for 24 hrs. After incubation, the 4 mL solutions of growth media were 
diluted to approximately 10% of the original concentration by adding 36 mL of TSB, 
subsequently referred to here as E. coli broth stock. 200 µL aliquots of broth stock were 
then placed into each microwell. Five separate sample types were prepared: assay blank 
using TSB and no bacteria, positive control with bacteria in 30 µg mL-1 CAM, and, 
bacteria in 1 mg mL-1 concentrations, separately, of LF, 10/1 NLF, and 40/1 NLF. 5 µL 
of E. coli broth stock was added to each well and incubated at 37ºC overnight. Finally, 
the absorbance of each well was examined at a wavelength of 600 nm using a plate reader 





3.3.4 Circular dichroism assay to determine the secondary structure 
CD spectra were recorded using the Jasco Model J-810 spectro-polarimeter using: 
a 1.0 mm path length quartz cell for absorption in the far-UV region (190 – 250 nm), scan 
speed of 20 nm/min, bandwidth of 1.0 mm, digital integration time of 4 sec per nm, and 
data pitch 1 nm. LF and NLF samples were diluted in PB buffer for analysis. Dilution 
calculations were performed using the molecular mass of LF, irrespective of the minor 
change in mass due to nitration.  
3.3.5 Preparation of iron-bound lactoferrin and detection of iron concentration  
The iron-loading assay was prepared following procedures outlined by Hamilton 
et al. (Hamilton, et al. 2009). After nitration reaction samples were purified, each 
UV-microwell was coated with 200 µL of either LF, 10/1 NLF, or 40/1 NLF. To 
each well, 20 equivalents of Fe(NTA)2 were added, and the absorbance was measured 
using the plate reader after 45 minutes of waiting at room temperature and  then analyzed. 
The absorbance of each well was detected using the plate reader at wavelength 470 nm. 
The ferrozine method was used to determine the iron uptake following a method 
reported by Stookey et al. (Stookey 1970). The protein concentration was measured using 
the Bradford assay. 100 µL samples consisting of 19.0 µM of each protein were 
diluted into nanopure water. A blank consisting of only water was also prepared. 10 µL 
of 3 M of trichloroacetic acid was added to each sample and centrifuged at 14000 g for 





nanopure water, 20 µL of 10 mM ferrozine, and 20 µL of saturated sodium acetate. 
Each mixture was analyzed at absorbance 562 nm (ε 27.9 mM-1 cm-1). 
3.3.6 Data analysis  
Igor Pro 7 software (Wavemetrics, Inc.; Oregon, USA) was used to analyze 
results. Bacterial cultures were grown in replicates three to five, each culture referred to 
as an individual experiment. All assay measurements were also performed at a minimum 
of triplicates of technical replicates, i.e. three wells individually prepared. For 
experiments involving bacterial cultures, values were first averaged from technical 
replicates and are represented here as averages of individually cultured experiments. Data 
shown represent mean ± standard deviation (s) of data values. Results were 
subjected to t-tests, including associated p-values calculated using the unpaired t-
test function in Microsoft Excel (i.e. ttest (Series1, Series2, 1,2)). 
The protein secondary structures of CD samples were analyzed using β-
Structure Selection (Bestsel) software available as online freeware (Micsonai, et al. 
2015). 
3.4  Results 
3.4.1 Broth antibacterial assay for LF  
The broth antibacterial susceptibility assay has previously been used to measure 
the minimum inhibitory concentration by using a visible measure of bacterial growth to 
determine the lowest concentration at which an antimicrobial agent was effective against 





the protocol was applied to quantify the inhibitory effect of LF and nitrated LF (NLF) 
against E. coli growth. Samples of E. coli were incubated separately under five conditions 
to first demonstrate the antibacterial activity of LF and to test the optimized assay 
conditions. Figure 3. 1 shows the relative density of bacterial cell number as the 
absorbance of the suspension measured at 600 nm. Growth inhibition is thus related by 
the reduction in absorbance compared to the negative control (E. coli only) samples. The 
blank (no E. coli) is defined as no growth. Chloramphenicol (CAM), used as strong 
antibiotic, shows near complete inhibition of growth, and LF shows partial inhibition at 
each protein concentration. Experimental concentrations of LF were chosen to match the 
approximate range present in ocular tear fluid in the normal eye (~2.0 mg mL-1) and 
during ocular disease (<2.0 mg mL-1) (Ballow, et al. 1987). Results confirm that the 
optimized assay shows increasing  E. coli growth inhibition with increasing concentration 
of added LF, as was previously shown by Kutila et al. over a range 0.7 – 2.7 mg mL-1 





Figure 3. 1 Optimized antibacterial assay. Absorbance at 600 nm shown for blank (broth, 
no E. coli), CAM (positive control, strong inhibition), E. coli (negative control, no 
inhibition) tested against LF at three concentrations: 0.5, 1.0, and 2.0 mg mL-1. Bars 
show mean values ± standard deviations of three individually cultured experiments. 
Absorbance values shown without blank subtraction. 
 
3.4.2 Antibacterial activity of LF and NLF 
The optimized broth antibacterial assay was subsequently used to determine the 
antibacterial activity of nitrated lactoferrin (10/1 and 40/1 molar ratios of nitrating agent 













Figure 3. 2 shows that LF inhibited E. coli growth by LF to be ca. 12%. In 
contrast, both concentrations of NLF show no inhibitory effect with respect to E. coli. 
Antibacterial inhibition tests show that 10/1 and 40/1 NLF exhibit p-values of <0.00005 
and <0.005 when compared to cultures treated only with LF. Further, both NLF cultures 
show growth properties to be insignificantly different (ns) from E. coli cultures grown 
without any kind of LF or NLF treatment. These results suggest that modifying the LF 
through nitration at molar ratios of both 10/1 and 40/1 was sufficient to remove all of the 



















Figure 3. 2 Antibacterial activity of LF vs. NLF. Absorbance at 600 nm shown for blank-
corrected absorbance values for E. coli grown against LF, 10/1 NLF, and 40/1 NLF (1.0 
mg mL-1 each). Bars show mean values ± standard deviations of five individually cultured 
experiments. Absorbance value for each experiment averaged from measurements of four 
technical replicates. P-values show statistical significance of differences in inhibition 






3.4.3 Secondary protein structures of LF and NLF 
To investigate conformational changes in the secondary structure of LF before 
and after nitration, four samples of LF, with and without nitration and with and without 
bound Fe3+, were analyzed using CD spectroscopy. The far-UV wavelength range (i.e. 
190-250 nm) probed by CD spectroscopy reveals information about the folding properties 
of the protein through its secondary structure (Kelly, et al. 2005). Three CD spectra of 
each sample were averaged and are shown in Figure 3. 3. 
The spectral minima for LF shifted approximately 10 nm to lower wavelength 
upon nitration (red → blue traces) for both the apolactoferrin (iron-free) and 
hololactoferrin (iron-bound) samples. The secondary structures associated with the 
protein samples were then analyzed using the Bestsel online software (Micsonai, et al. 
2015). As expected from its crystal structure (Anderson, et al. 1989a), the measured CD 
spectrum of lactoferrin confirms it to be a well-folded protein of primarily alpha-helical 
character (Figure 3. 3). Iron binding was found to not significantly change the spectra in 







Figure 3. 3 Secondary protein structure via circular dichroism spectroscopy. CD spectra 
of LF (red solid trace), 10/1 NLF (blue solid trace), LF-Fe (red dashed trace), and 10/1 
NLF-Fe (blue dashed trace) acquired between 190 and 250 nm. Spectra shown as 
averages of three readings. Y-scales independently scaled to highlight overlap of 
spectra.3.4.4 Iron-binding ability of LF and NLF 
To examine the ability of the protein to bind iron, samples of LF and NLF were 
subjected to two iron-binding assays. In the case of NLF, Fe3+ was added to the samples 
after nitration reactions were complete. Results from both assays qualitatively show a 
reduction in the ability of LF to bind iron after nitration, with increasing effect from 






Table 3.1 Iron determination data. LF and NLF samples listed as blank-subtracted values. 








Blank 0.38 0.031 
LF 25.5 0.072 
NLF 10/1 22.0 (-13%) 0.010 (-74%) 
NLF 40/1 19.1 (-24%) -0.006 (-110%) 
 
3.5 Discussion 
The relationship between LF concentration and bacterial inhibition was shown 
here to exhibit approximately linear behavior (Figure 3. 1), consistent with observations 
shown by Ellison et al. (R. T. Ellison, et al. 1988). A reduction in the antibacterial 
activity of LF upon nitration had not been previously observed, however. Inhibition of 
the antibacterial activity is consistent with charge-related properties of the interaction 
between E. coli and LF. Gram-negative bacteria can generate inflammatory mediators 
such as LPS bound within the outer bacterial membrane, and these mediators can induce 
cytotoxicity in humans (Heumann, et al. 2002). LF proteins within human fluids act to 
protect against the toxic effects by binding to LPS and thus damaging the bacterial 
membrane (Lönnerdal, et al. 1995). The mechanism by which LF kills gram negative 





by cationic regions of LF concentrated at the N-terminus (Bellamy, et al. 1992; Erdei, et 
al. 1994). Nitration has been shown to add anionic nature to protein structure (Ignarro, et 
al. 1995). For example, the reaction of LF with ONOO- adds nitro groups (NO2) to 
aromatic amino acid residues such as tyrosine (Alhalwani, et al. 2018), thereby increasing 
the anionic charge of the protein. The corresponding decrease in cationic surface 
properties of the protein would thus be expected to reduce the binding of LF to LPS, 
leading to a decrease in the antibacterial properties of LF qualitatively consistent with the 
results shown in Fig. 3. 2.  
Separate from the ionic properties of LF that affect bactericidal activity, the 
secondary structure of native LF is critical to its antibacterial function (Japelj, et al. 
2005). Teuwissen et al. showed that nitration of apolactoferrin using tetranitromethane 
(TNM) changed the tertiary protein structure sufficiently to reduce its ability to uptake 
iron (Teuwissen, et al. 1973). TNM is not a physiologically relevant nitrating agent, 
however, and so the extrapolation of effects within the body is not obvious. It was also 
previously shown that ONOO- present at physiologically relevant concentrations can 
efficiently nitrate LF (Alhalwani, et al. 2018). The secondary structure of LF has 
separately been investigated many times using CD spectroscopy (Kang, et al. 1996a), 
however, no previous reports had shown changes in LF structure associated with ONOO- 
nitration. Here we showed for the first time that LF nitration induced by ONOO- can 
cause significant changes to the protein structure (Fig. 3. 3). Quantification of structural 





undergoes a drop in both the alpha-helical and beta-parallel sheet character upon 
nitration. Similarly, LF nitrated after saturation with Fe3+ resulted in a drop in alpha-
helical character by approximately half. Nitration of lactoferrin in both unligated and 
iron-bound cases thus causes significant changes in secondary structure that suggests 
partial protein unfolding. The LF nitrated without bound iron, however, shows relatively 
greater reduction in the alpha-helical spectral region than iron-bound LF.  This may 
suggest that the bound Fe3+ stabilizes the protein and also protects against nitration of the 
two tyrosine residues in each binding site. These possibilities will need to be probed in a 
future study. 
Our observations conceptually match results for a structurally similar protein 
alpha-Crystalline, shown to exhibit misfolding after nitration with ONOO- (Thiagarajan, 
et al. 2004). Several studies have shown that alpha-helical peptides from LF provide 
bactericidal activity against E. coli. (Chapple, et al. 1998; Håversen, et al. 2000). Elass et 
al. also showed that LPS in E. coli interacted with the alpha-helical region of LF peptides 
and caused membrane damage (Elass-Rochard, et al. 1995). Here we showed a reduction 
in the CD spectral band in alpha-helix regions (208 and 222 nm). Together, the 
complementary observations suggest that nitration within the alpha-helical structure of 
the LF protein is likely to partially explain the reduction in antibacterial activity for NLF.  
A separate test of iron-binding ability for both LF and NLF samples showed a 
qualitative decrease in iron uptake after nitration. These tests will need to be duplicated at 





significance, and to quantitatively calculate iron binding constants. The initial evidence 
shown, however, is suggestive that iron uptake by LF is diminished upon nitration.  
The observations here are the first to show that NLF exhibits reduced antibacterial 
activity compared to native LF. These results have critical relevance to nitration 
pathways within the human body as a function of inflammation and environmental 
exposure. For example, ONOO- levels have been shown to increase dramatically during 
eye inflammation (Allen, et al. 1998), which suggests that proteins such as LF in ocular 
fluids are likely to exist in at least partially nitrated states. LF converted to NLF in these 
nitrosative environments are thus likely to increase the possibility of bacterial infection, 
which can dramatically exacerbate ocular stress. The exposure of proteins within ocular 
fluid and in mucous membranes of the lungs and nasal passages can also be exposed to 
nitration through interaction with urban pollutant gases such as NO2 and O3 (Shiraiwa, et 
al. 2012). Protein nitration reactions have been proposed to provide a mechanism by 
which allergic and toxic responses are increased. Our observations thus represent a 
possible link to biochemical modification pathway during diseases and due to 
environmental exposure.  
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Chapter four: Ergothioneine inhibits nitration of proteins and can enhance natural 
antibacterial activity 
4.1 Abstract 
Ergothioneine (Ergo) is a natural product compound with antioxidant activity. It is 
accumulated in high concentration in many mammalian tissues including the eye. Ergo 
decreases in concentration within aging adults and may correlate with the presence of 
aging-related disease (Cheah, et al. 2016). This study was to investigate the Ergo 
contribution to protecting several proteins from nitration effects. The nitration reactions 
were applied using ONOO- and TNM nitration agents with and without the presence of 
Ergo. The nitration products were analyzed using absorbance and fluorescence 
spectroscopy and were compared with respect to non-nitrated proteins. The quantification 
of the nitrotyrosine level was also detected via the ELISA technique. The antibacterial 
function of nitrated lactoferrin was tested by broth microplate antibacterial assays. Our 
results show that Ergo exhibits anti-peroxynitrite activity by reducing nitration, and Ergo 
exhibits anti-inflammatory activity by restoring the antibacterial activity. This 
investigation will play a role for Ergo in prevent oxidative and nitrosative ocular damage. 
4.2 Introduction 
There are many nitration inhibitors, including   ergothioneine (Ergo). Ergo has 





molecular weight of approximately 229 Da (Hartman 1990) , is a safe, natural product 
compound, is odorless, is colorless, does not autoxidize, has high solubility in aqueous 
solutions up to 0.9 M, is stable, and degrades slowly in the physiological system.  
Ergo is synthesized in fungi and mycobacteria, but there is no evidence for 
presence of  biosynthesis in mammals or higher plants (Melville, et al. 1954). It is 
accumulated in several parts of the human body in concentrations of 1.0-2.0 mM such as 
lens of the eye, the cornea, the liver, and in bone marrow (Melville, et al. 1954). The 
presence of a high level of Ergo in mammalian ocular tissue has previously been 
determined, suggesting that it accumulates after being eaten (Shires, et al. 1997). 
Ergo has many functions (Cheah, et al. 2012); as an antioxidant, as an Ergo tumor 
necrosis factor (TNF-α), as a hydrogen peroxide (H2O2) inhibitor in alveolar epithelial 
cells (Rahman, et al. 2003).  As an anti-peroxynitrite agent, Ergo inhibits peroxynitrite-
dependent reactions and protects tyrosine from nitration (Aruoma, et al. 1997). As an 
anti-inflammatory, Ergo inhibits xanthine and hypoxanthine formation (Žitňanová, et al. 
2004). The multifunctionality of Ergo shows the possibility for therapeutic usage in many 
diseases, such as cardiovascular diseases (Servillo, et al. 2017) and acute respiratory 
distress (Repine, et al. 2012). Ergo is a well-known anti-peroxynitrite, anti-oxidant, and 
anti-inflammatory substance (Franzoni, et al. 2006b; Cheah, et al. 2012). One of the main 
Ergo antioxidant mechanisms is the capture of free radicals such as hydroxyl radical, and 
peroxynitrite. To my knowledge there is no reported mechanism in arrow reaction for 





The aim of this work is to investigate the nitration inhibition effect of Ergo using 
several nitrated proteins samples; bovine serum albumin, lactoferrin, and lamb cornea 
lysate. Described here are several techniques used to examine Ergo’s inhibition activity, 
including ELISA and spectroscopy techniques. Also shown is the broth antibacterial 
assay used to examine LF’s antibacterial activity. 
4.3 Experimental  
4.3.1 Materials  
Ergothineine (Ergo, 26524) were obtained from OXIS international, Inc. Human 
milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030), tetranitromethane 
(TNM; T25003), Tween®20 buffer (P1379), Trizma base (Tris-HCl; T1503), sulfuric 
acid (H2SO4; 320501), sodium phosphate dibasic (RES20908-A702X), potassium 
chloride (P9333), sodium chloride (S9625), potassium phosphate monobasic (P5655), 
sodium carbonate (S7795), sodium bicarbonate (S5761), glysrol (G9012), and ethanol 
(245119), 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl) 
piperazine-N′-(2-ethanesulfonic acid) (HEPES; H3375), Triton X-100 (X100), 
ethylenediaminetetraacetic acid anhydrous, bioultra (EDTA), chloramphenicol antibiotic 
(CAM; C0378), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020), Tryptic 
Soya broth (TSB; 22092), and Tryptic Soya agar (TSA; 22091) and sodium chloride 
(S9625) were purchased from sigma-aldrish (USA).  
HALT (tm) protease inhibitor (PI; QB203967A) from fisher scientific company 





filters (30 kDa, 0.5 mL size; UFC503008) and Amicon Ultra centrifugal filters (30 kDa, 4 
mL size; UFC803024) were purchased from Calbiochem (USA).  
The 1-step ultra 3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and 
bicinchoninic acid assay (BCA; 23225) for total protein quantification were purchased 
from ThermoFisher Scientific (USA). Flat-bottom, 96-microwell plates (untreated; 333-
8013-01F) and sterile sealing tape (ST-3095) were obtained from Life Science Products 
(USA). A biotinylated, mouse monoclonal to nitrotyrosine antibody (α-NTyr; ab24496), 
streptavidin horseradish peroxidase (HRP; ab7403), and non-conjugated goat polyclonal 
anti-human lactoferrin antibody (α-LF; ab77548) were obtained from Abcam (UK). 1.0 
mL quartz cuvette with 10mm path length (MF-W-10-LID) was purchased from Science 
Outlet (USA).  
Biotinylated, mouse monoclonal to nitrotyrosine antibody (α-NTyr; ab24496), 
non-conjugated goat polyclonal anti-human lactoferrin antibody (α-LF; ab77548), and 
streptavidin horseradish peroxidase (HRP; ab7403) were obtained from Abcam (UK). 
100 mm x 15 mm petri dish with grip ring, sterile (229692) provided by CELLTREAT 
(USA). UV 96-microwell plate with a transparent flat bottom (3635) was purchased from 
CORNING (USA).  
Escherichia coli (E. coli; ATCC25922) was purchased from the American Type 
Culture Collection, ATCC (USA). Lamb cornea (age: 3 months, male gender) was 
donated from local butcher store (Jerusalem Market, E. Illif Ave.), it was FDA approved 





Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate 
dibasic, 0.8 mM sodium phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM 
sodium chloride at pH 7.4), Tris-HCl buffer (Tris; 0.1 mM at pH 8.0), carbonate buffer 
(29.0 mM sodium carbonate and 71.0 mM sodium bicarbonate at pH 9.6), tryptic soy 
broth, and tryptic Soy agar was prepared following the manufacture instructions, 
and  extraction buffer (EB) solution (50.0 mM Tris-HCl, 10.0 mM HEPES, 150.0 mM 
NaCL, 5.0 mM EDTA, 0.5 % Triton at pH 7.7, and then fresh add 10 % protease 
inhibitor (PI) and Tris-HCl buffer (Tris; 50 mM at pH 8.0). 
The volume of peroxynitrite used for production of NLF10/1 ONOO- sample 
discussed in Section 4.4.2 was 5.66 µL. Similarly, the volume of TNM used for 
production of NLF10/1TNM discussed in Section 4.4.2 was 0.29 µL. The volume of 
tetranitromethane used for production of NBSA6/1 discussed in Section 4.4.1 was 0.95 
µL of 6/1. The volumes of (17.05 µL) peroxynitrite and (1.16 µL) tetranitromethane used 
for production of nitrated cornea lysate ONOO- and TNM samples. These values correspond 
to molar ratios of nitrating agent to tyrosine (ONOO-/Tyr) or (TNM/Tyr).  
Proteins samples were tested: (1) BSA, NBSA 6/1(TNM), NBSA6/1(TNM)- 
Ergo 0.1 and 1.0 mM, (2) LF, NLF10/1(TNM), NLF10/1(TNM)- Ergo 0.1 and 1.0 
mM, (3) LF, NLF10/1(ONOO-), NLF10/1(ONOO-)-Ergo 0.1 and 1.0 mM,(4) cornea 
lysate, nitrated cornea lysate (TNM), and nitrated cornea lysate (TNM)- Ergo 5.0 mM, 
and (5) cornea lysate, nitrated cornea lysate (ONOO-), and nitrated cornea lysate 





4.3.2 Protein nitration reaction  
The nitration reactions protocol followed procedures outlined by Alhalwani et al. 
to produce nitrated BSA, nitrated LF, and nitrated cornea lysate using TNM or ONOO- 
(Alhalwani, et al. 2018). Briefly, TNM reaction occurs in a mixture of Tris-HCl buffer 
and 20% ethanol, followed by added TNM volume based in a preferred TNM/Tyr molar 
ratio and serried at RT for 3 hours. The ONOO- reaction occurs in PBS buffer at a 
preferred ONOO-/Tyr molar ratio and serried in ice for 3 hours. Then, each nitration 
model (TNM or ONOO-) has two nitration groups, one group with Ergo and another 
group without Ergo. Ergo was added to the protein before adding the nitration agents to 
work efficiently in protecting the protein from nitration modification. The nitration 
reaction for cornea lysate was performed by adding the same concentration of each 
nitration agent.  
The nitration product was purified using Amicon centrifugal tube and the protein 
was quantified using BCA assay following the manufacturer's protocol.  Instruments 
were used; UV-vis spectrophotometer (Cary BIO 100), fluorimeter (Carry eclipse), 
rocking platform (UltraRocker, BIO-RAD), and plate reader (Tecan Infinite, M1000 
PRO).  
4.3.3 Absorbance analysis   
The UV-Vis analysis used wavelength range of 250-500 nm and 2 nm steps 
obtained the absorption spectra. The protein samples were analyzed at RT using a 





reaction buffer PBS or Tris-HCl. The dilution of protein samples was calculated 
based on the molecular mass of native protein, irrespective of mass changes due to 
nitration. 
4.3.4 Fluorescence analysis   
The fluorescence analysis used excitation wavelength at 280 nm which is related 
to higher fluorescence of tyrosine and tryptophan. The fluorescence detected in a 2 nm 
increment at RT using a 10.0 mm quartz cuvette.  Sample concentrations were 0.2 
mg/mL and diluted in a proper reaction buffer PBS or Tris-HCl. The result shows a 
correlation between excitation wavelength and the corresponding emission intensity. The 
fluorescence spectra were used to determine the difference between the chemical 
structure properties and the native, nitrated protein, and nitrated protein-Ergo. 
 
4.3.5 (NTyr) Direct enzyme linked immunosorbent assay (ELISA) to determine 
nitrotyrosine level 
To detect the differences in nitrotyrosine between protein samples, direct ELISA 
was used to quantify the nitrotyrosine residue in the following samples: NBSA 
6/1(TNM), NBSA 6/1(TNM)- Ergo 0.1 and 1.0 mM, Cornea lysate, nitrated 
lysate(TNM)- Ergo 5.0 mM, and nitrated lysate(ONOO-)-Ergo 5.0 mM. BSA was used 
because it is a standard protein and has 21 tyrosine residues, which is similar to the 20 





Here, samples were diluted into a carbonate buffer at concentration 5 µg mL-1. 
The samples were coated in triplicate with each sample solution and added separately to 
three wells as a blank measurement. The plate was covered with tape and incubated at RT 
for 2 hours.  Washing steps to each well was applied after the incubation using 200 µL of 
PBST (PBS with 0.05% Tween) followed by patting the plate with a laboratory wipe to 
take away the extra washing buffer, repeated twice. This step was repeated after each 
incubation step with the same process of covering and plate shaking while incubation 
time using a rocking platform and then washing steps using PBST.  
After washing, the plate was blocked by the non-specific binding areas using 200 
µL of blocking buffer (5% BSA in PBS). This was added to each well and incubated at 
RT for 2 hours. Following the washing step, mouse monoclonal to nitrotyrosine 
biotinylated antibody (α-NTyr) was diluted in blocking buffer in 1:500 dilution ratio and 
50 µL of the dilution was added to each well and incubated at RT for 1 hour. After that, 
streptavidin-HRP diluted 1:10,000 in blocking buffer was added in 50 µL to each well 
and incubated at RT for 1 hour. The TMB substrate was added in 100 µL to each well 
and incubated at RT until the color developed from colorless to blue in about 10 minutes. 
The 0.5 N aqueous sulfuric acid was added in the top of the substrate and the color 
quickly changed to yellow.  
The plate was measured using the optical absorbance of each well using a 





(Rajasekariah, et al. 2003). The final absorbance is a value of the subtracted background 
wavelength 620 nm (blue) from the wavelength at 450 nm (yellow).   
4.3.6 (LF- NTyr) Sandwich ELISA for quantify nitrotyrosine 
The sandwich ELISA protocol was followed by Alhalwani et al.(Alhalwani, 
et al. 2018) which is a unique combination of antibodies which are that the 
captured antibody was goat polyclonal to lactoferrin non-conjugated antibody (α-
LF), and the detector antibody was mouse monoclonal to nitrotyrosine biotinylated 
antibody (α-NTyr) to detect nitrotyrosine in LF molecules.  
The microplate was coated with 50 µL of 1:1000 dilution ratio of captured 
antibody in carbonate buffer at at 4°C overnight. The plate was then washed and 
blocked as described above. After the washing step, 50µL of NLF10/1(TNM), 
NLF10/1(TNM)- Ergo (0.1 and 1.0 mM), NLF10/1(ONOO-), and NLF10/1(ONOO-)-
Ergo (0.1 and 1.0 mM) that were diluted into the blocking buffer to produce NLF 
solutions of concentrations 5 µg mL-1 and added in triplicate to the plate and 
incubated at RT for 1 hour. Blocking buffer was used for blank measurements. The 
detector antibody diluted in blocking buffer was added in 50 µL of 1:100 dilution 
ratio and the plate was incubated with shaking at RT for 1 hour.  The enzyme 
streptavidin-HRP and the substrate TMB were added following the ELISA protocol, 
as described above. The standard calibration curve was made according to the 





4.3.7 Broth microplate antibacterial assay to detect the antibacterial activity 
The assay was followed by broth microplate antibacterial assay in previous study 
(Jorgensen, et al. 2015; Balouiri, et al. 2016). E. coli broth stock was prepared from 1 µL 
of glycerol stock aliquot of E. coli was inculcated into TSA plates at 37 ºC for 24 hrs. 
Then, several (3-5) separate colonies were selected, transferred into 4 mL TSB, and 
incubated at 37 ºC for 24 hours. Finally, the 4 mL of E. coli in TSB was diluted 10% 
dilution by adding 36 mL of TSB to make E. coli broth stock.   
In the microplate, TSB (200 µL) was added with the samples. All samples were 
prepared in TSB, (Blank) using TSB, (positive control) in CAM in 30 µg mL-1, LF, Ergo, 
NLF (ONOO-)10/1-Ergo 0.2, 1.0, 5.0 and 10.0 mM, and NLF (ONOO-) 10/1, 20/1, 
30/1, and 40/1 Ergo 5.0 mM all NLF’s samples were in 1.0 mg mL-1concentrations. 
In each well, 5 µL of E. coli broth stock was added and incubated overnight at 37 ºC. The 
microwell plates were examined at wavelength 600 nm using the plate reader. 
4.3.8 Lamb cornea tissue dissection  
The lamb cornea was extracted from the whole lamb eye using a surgical razor 
blade. Then, the cornea was cut into four pieces, weighted using an analytical scale, and 
followed by a snap freeze using liquid nitrogen. The cornea was placed in a cryogenic 
microtube and stored at -80°C until extraction occurs, see appendix B.  
4.3.9 Protein extraction from lamb cornea 
The cornea was washed using Tris-HCl buffer and placed into the extraction 





sonicated at 8 powers for 2 minutes. Finally, the mixture was centrifuged at 1400 g for 30 
minutes and the supernatant was collected and aliquot in cryogenic microtube and stored 
at -20°C until further analysis. The total protein in the lysate was detected using BCA 
assay following the manufacture protocol.   
4.3.10 Statistical analysis  
All data were analyzed using Igor Pro 7 software (Wavemetrics, Inc.; 
Oregon, USA). All ELISA and bacterial samples were run in triplicate, averaged, and 
represented mean ± standard deviation (s) of data values. Analyses of variance were 
subjected to t-tests, including associated p-values performed using GraphPad 
software.  
4.4 Results and Discussion 
4.4.1 Nitrated standard protein NBSA 6/1(TNM) used to characterize nitration 
inhibition via Ergo 
The TNM nitration reaction was used to produce nitrated protein with the highest 
NTyr residues since the nitration reaction by TNM reagent mainly produce NTyr residues 
in the protein. An Ergo concentration of 1.0 mM was used as an effective inhibitory 
concentration against NTyr formation as has been shown in  previously published reports 
(Aruoma, et al. 1997) Addionally, the NTyr formation was tested to detect the effective 
dose of inhibition using sandwich ELISA which confirm this concentration. The result of 
Sandwich ELISA shows the correlation between the reduction of NTyr formation and 






Figure 4. 1 Sandwich ELISA for NLF 10/1 and Ergo. The NLF 10/1 shows similar NTyr 
formation at Ergo 1mM and higher concentrations.  
  
 The NBSA 6/1(TNM) was used to test inhibitory effects of Ergo against 
nitration, (Figure 4. 2) using three analytical methods. Absorbance intensity at 350 nm 
obtains information about the nitration formation through the increase in nitrated product 
absorbance. The spectra of NBSA 6/1 (Figure 4. 2. A) showed higher absorbance 
intensity than NBSA with Ergo. The decrease in absorbance band indicates the inhibition 
effects of Ergo to nitration formation. Additionally, the fluorescence intensity at 
excitation 280 nm identifies the nitration formation by diminishing the intensity. The 
fluorescence spectra of NBSA 6/1 showed lower fluorescence intensity than NBSA with 
Ergo (Figure 4. 2. B). The increase in fluorescence band shows the inhibition effects by 
Ergo. Nitrotyrosine (NTyr) is a marker for the nitration formation and to determine the 





ELISA quantifies nitrotyrosine residues which indicate the nitration formation. The result 
of NBSA 6/1 (Figure 4. 2. C) detected higher NTyr concentration than NBSA with Ergo.  
The three analyses each suggest that NBSA 6/1 has the highest nitration formation 
comparing to NBSA 6/1-Ergo 0.1 and 1.0 mM. These results together confirmed the 
inhibition effects of Ergo to the nitration. There was a direct correlation between the Ergo 
concentration and the nitration inhibition e.g. NBSA 6/1-Ergo1.0 mM had less nitration 
than NBSA 6/1-Ergo 0.1 mM. Our results are consistent with the study by Aruoma et 
al.(Aruoma, et al. 1997) that showed the association between the decrease in 
nitrotyrosine residues to the increase of the concentration of Ergo. Here, we used NBSA 
6/1 as standard protein to help in adjusting the analysis for our target protein LF and 
cornea lysate. 
 
Figure 4. 2 The results of the effect of Ergo in NBSA 6/1. Three data sets presented are 
A: absorbance (blue mark), B: fluorescence (red mark), and C: direct ELISA n=3 (green 
mark) showed the nitration chemical properties with respect to Ergo effects. In each 
graph, the samples presented at x-axis were from right to left were NBSA 6/1(TNM), 
NBSA 6/1(TNM)- Ergo 0.1, and NBSA 6/1(TNM)- Ergo 1.0 mM.  
4.4.2 Nitrated human protein NLF10/1 used to test Ergo inhibitory property    
Herein, we nitrated lactoferrin using two models; TNM to produce mainly 3-
nitrotyrosine (NTyr ) and as nitration exogenesis model, and ONOO- to produce several 





control for the nitration formation and to compare it with the samples of NLF10/1with 
Ergo.  
The spectroscopic results (Figure 4. 3. A and B) showed an increase in 
absorbance intensity at 350 nm and a decrease in the fluorescence intensity at excitation 
280 nm for NLF10/1 and these effects inverted after the addition of Ergo. The result of 
NLF10/1 with TNM was consistence to NLF10/1 with ONOO-. The results of NLF and 
NBSA confirmed the Ergo inhibitory effects against protein nitration. In our previous 
study, we developed a specific sandwich ELISA that detects NTyr in nitrated lactoferrin 
samples (Alhalwani, et al. 2018), thus, the level of NTyr residues were determined using 
this sandwich ELISA. The sandwich ELISA quantifies nitrotyrosine residues (Figure 4. 3. 
C) which confirm the nitration formation. The NLF10/1 showed higher NTyr residues 
than NLF10/1 with Ergo.  
The results of NLF10/1 with Ergo showed a decrease in NTyr residues with the 
increase of Ergo concentrations. This finding suggests that Ergo protects lactoferrin 
protein from nitration. By contrast, the link in both nitration agents ONOO- or TNM is to 
produce NO2 in the reaction environment and cause protein nitration. We observed that 
NLF with ONOO- or TNM has similar inhibition response via Ergo. This observations 
lead to the possible Ergo inhibition mechanism by capturing an NO2 molecule to prevent 






Figure 4. 3 The results of the affect of Ergo in NLF 10/1. A: absorbance in blue, B: 
fluorescence in red, and C: sandwich ELISA in green demonstrated the nitration 
chemical properties with respect Ergo effects. The circle presented NLF’s (TNM) 
samples and the triangle presented NLF’s ONOO- samples.  
4.4.3 Nitrated cornea tissue proteins used to investigate Ergo inhibitory property 
The goal of this part of the work is to investigate the changes associated with 
certain proteins due to nitration on an organ level. The inhibitory effects of Ergo will help 
us to understand the nitration of these proteins en route to understanding their potential 
importance in eye diseases and possibly toward finding a therapeutic target. Here, the 
cornea tissue was tested since it has been shown that LF presence in mammalian cornea 
and protein effects (Rageh, et al. 2016). The cornea lysate sample contains mixtures of 
proteins including lactoferrin and the nitration will produce multiple protein nitrations.  
The Ergo concentration (5.0 mM) was higher than NBSA and NLF experiments 
to extend the highest level of protection, since the cornea lysate has many different 
proteins and the nitration formation level was unknown. The absorbance data (Figure 4. 
4. A) showed decrease in intensity due to the reduction of nitration formation by Ergo, 
and the fluorescence data (Figure 4. 4. B) showed the increase in intensity via retraining 
the fluorescence chemical properties via Ergo. The direct ELISA (Figure 4. 4. C) 





inhibitory effects of Ergo in lysate samples were matched to the above results for NBSA 
and NLF which confirmed the anti-peroxynitrite activity of Ergo. This investigation 
verified the robust ability of Ergo effects to protect proteins from the nitration process. 
 
Figure 4. 4 The results of the affect of Ergo in N-lysate. A: Absorbance spectra in blue 
mark, B: fluorescence spectra in red mark, and C: direct ELISA spectra in green mark.  
4.4.4 The antibacterial activity retrained for NLF after the addition of Ergo 
LF plays an important role in the antimicrobial function via several mechanisms. 
In this study, the bacteria growth was monitored using visible absorbance at 600 nm. The 
protein nitration using ONOO- was tested for lactoferrin since it is related to the 
physiological nitration process and because Ergo has anti-peroxynitrite activity 
(Franzoni, et al. 2006b). The protein nitration using TNM was not suitable for 
antibacterial assay due to its toxicity. The antibacterial assay was tested for controls 
which are LF, Ergo 5.0 and 50.0 mM as result showed in Figure 4. 5. Also, Ergo results 
(Figure 4. 6. A and B) represented two different inhibitory models for Ergo to lactoferrin 
nitration. 
First, (Figure 4. 6. A) showed the effects Ergo in different concentration to one 
molar ratio of nitrated lactoferrin. E.coli was tested against in several samples and 





lower inhibition for NLF10/1 (12%) than NLF10/1-ERG 0.2 mM (-9 %), 1.0 mM (-2%), 
5.0 mM (25%) and 10.0 mM (34%). The two concentrations NLF10/1-ERG 0.2 mM and 
1.0 mM have a technical error and that explained the negative values.  The E.coli linearly 
inhibited with the increase of Ergo concentration in nitrated lactoferrin samples which 
indicate antibacterial activity was protected during nitration by Ergo. P-values of E. coli 
against all samples were < 0.001 significantly different except NLF10/1-ERG 1.0 mM < 
0.1 due to a technical error.  
Second, (Figure 4. 6. B) showed the effects nitrated lactoferrin in different 
nitration molar to one concentration of Ergo 5.0 mM. E.coli was tested against many 
samples; LF (23%) highest growth, higher inhibition in NLF10/1-Ergo 5.0 mM (45%), 
NLF 20/1-Ergo 5.0 mM (32%), NLF30/1-Ergo 5.0 mM  (21%) and NLF40/1-Ergo 5.0 
mM (22%). P-values of E. coli against all samples were <0.001 significantly different. 
The Ergo 5 mM concentration in NLF10/1 inhibit the nitration and bacterial growth 
greater than the higher nitration molar NLF40/1. The presence of same Ergo 
concentration (5 mM) with a different NLF molar ratio showed a competitive reactivity 
of Ergo in protecting the protein from nitration, but generally, showed nitration 
inhibition. This confirmed the importance of the dose response of Ergo with respect to 






Figure 4. 5 Antibacterial activity of controls Ergo 5.0 mM has antibacterial activity 








Figure 4. 6 .Broth microplate antibacterial assay. Blank (broth, no E. coli), CAM 
(positive control, strong inhibition), E. coli (negative control, no inhibition) tested 
against A: LF and NLF at four molar concentrations 10/1, 20/1, 30/1, and 40/1 with 
same Ergo concentration 5.0 mM, and P-values of E. coli against LF (0.0001), NLF10/1-
Ergo 5.0 mM (0.0001), NLF20/1-Ergo 5.0 mM (0.0001), NLF30/1-Ergo 5.0 mM 
(0.0008), and NLF40/1-Ergo 5.0 mM (0.0005). B: LF and NLF10/1 with four Ergo 
concentrations: 0.2, 1.0, 5.0, and 10.0 mM. Absorbance values shown without blank 
subtraction. Bars show mean values ± standard deviations of n=4. P-values of E. coli 
against LF (0.0001), NLF10/1 (0.0007),  NLF10/1-Ergo 0.2 mM (0.0043), NLF10/1-Ergo 






The present work showed initial results regarding the inhibitory effect of Ergo in 
the nitration reaction for several physiological proteins. Our observation of qualitative 
and quantitative analysis showed an inhibitory effect of nitration through the addition of 
Ergo. Specifically, BSA protein nitration with Ergo was significant dropping at NBSA- 
Ergo 1.0 mM comparing by NBSA. Also, LF protein nitration with Ergo and cornea 
lysate nitration with Ergo showed decrease in nitration in the two nitration models 
ONOO and TNM with slight different in inhibition due to the mechanism of producing  
nitration from each model. Finally, the antibacterial activity results of Ergo-NLF showed 
an increase of antibacterial activity than NLF.  
The results suggest a correlation between the decreases of the protein nitration 
level with the increase of Ergo concentration. This study demonstrated preliminary 
results for Ergo nitration inhibition in several nitrated proteins using quantitative and 
qualitative techniques, which could contribute to the potential treatment development for 









Chapter five: Conclusion and future work 
Protein nitration is a type of chemical modification that introduces nitro group 
into amino acid residues. The body can be exposed to nitration through various vectors, 
including via disease and air pollution. Certain proteins are highly affected by this 
nitration process, including lactoferrin. LF is widespread within bodily fluid and plays a 
role in health due to multitude of functions. Also, lactoferrin is used as a biomarker 
protein for several diseases. There is also a relationship between decreases in lactoferrin 
levels with many disease types, such as ocular disease.  
The incidence of ocular surface disease are actively increasing as air pollution 
continues to rise. Clinical examinations of the ocular surface have shown links between 
reactive nitrogen species in air pollution and disease incidence, but the exact mechanism 
of this link is unknown. The studies presented here investigate lactoferrin nitration using 
a series of biochemical techniques. The observed chemical effect nitrogen species have 
on lactoferrin was then applied to biological samples with the intent of finding a 
therapeutic approach to preventing ocular disease caused by nitration.   
Nitrotyrosine and lactoferrin, in tears, are both important biomarker targets for 
ocular disease. Biochemical studies on detecting the effect of nitration with respect to the 
decrease of lactoferrin in ocular disease are not well understood, so a method was 
developed which allows for simultaneous detection of both markers in a single assay. 





standards of lactoferrin, with different nitration molar ratios, reveal a linear dependence 
of binding between lactoferrin and nitrogen species. A unique, selective, and sensitive 
sandwich ELISA detection technique utilizing two antibodies, anti-lactoferrin and anti-
nitrotyrosine was then developed to quantify the amounts of nitrotyrosine in nitrated 
lactoferrin samples. The sandwich ELISA method detecting nitrotyrosine bound to 
lactoferrin is important in better understanding the biological role of the decreasing 
lactoferrin levels in ocular disease. 
Since lactoferrin is a host defense protein that protects the ocular surface, it’s 
given that a loss of lactoferrin function is one potential link to ocular disease. 
Considering the knowledge that nitration is linked to other air pollution disease this study 
investigates potential effects that nitration of lactoferrin may have on its bioactivity. A 
broth antibacterial assay shows lactoferrin’s antibacterial activity is diminished by 
nitration in a concentration dependent manner. This effect was explained using circular 
dichroism, in which spectra show conformational changes on lactoferrin due to nitration. 
These observations help elucidate the mechanism of how ocular disease can be linked to 
components of air pollution.  
Given the negative effects nitration has on lactoferrin function a method of 
inhibiting this nitration has high therapeutic potential in ocular disease. Ergothioneine, a 
natural histidine mimic, is currently used as an anti-inflammatory, anti-oxidant, and anti-
peroxynitrite agent. Because it is already utilized in other areas, ergothionene was chosen 





potential, we utilized previously discussed spectroscopic, antibacterial and ELISA 
techniques, and our results universally show that ergothioneine blocks nitration of 
lactoferrin. These finding show excellent potential in utilizing ergothioneine to maintain 
health of ocular surface. 
To better understand lactoferrin nitration within biological samples, I plan to 
utilize a quantitative sandwich ELISA technique on tear samples from patients with 
ocular surface disease. While tear analysis is one good way of investigating the effects of 
lactoferrin nitration in biological samples, more research is needed on lactoferrin nitration 
in living cells to evaluate whether they might exhibit altered function in vivo. To establish 
this, further research for the nitration reactions need to be explored for toxic effects with 
in vivo studies. Also, the quantification assay (ELISA) needs to be adjusted to the 
concentration range to quantify nitrotyrosine based on the matrix sample.   
We gained insight on the mechanism of this altered function by observing the 
reduction in the antibacterial activity of nitrated lactoferrin, but future molecular structure 
investigations will lead to more understanding in the antibacterial mechanism. Also, the 
degree of nitration and the location of nitrotyrosine on lactoferrin will support the 
investigation of antibacterial mechanism.  
Finally, ergothioneine is an excellent target molecule for inhibit protein nitration 
and help to maintain protein function, thus making it a robust treatment option with broad 
applications in ocular therapy. This project needs further investigation in vivo, in addition 





experimental designs, clinical examination, and the therapeutic improvements intended to 
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Appendix A: Supplementary material for chapter two 
A.1 Materials and reagents 
 Human milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030), 
tetranitromethane (TNM; T25003), Tween®20 buffer (P1379), Trizma base (Tris-
HCl; T1503), sulfuric acid (H2SO4; 320501), sodium phosphate dibasic 
(RES20908-A702X), potassium chloride (P9333), sodium chloride (S9625), 
potassium phosphate monobasic (P5655), sodium carbonate (S7795), sodium 
bicarbonate (S5761), and ethanol (245119) were obtained from Sigma Aldrich 
(USA). Sodium peroxynitrite (NaONOO; 516620) and Amicon Ultra centrifugal 
filters (30 kDa, 4 mL size; UFC803024) were purchased from Calbiochem (USA). 
The 1-step ultra 3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and 
bicinchoninic acid assay (BCA; 23225) for total protein quantification were 
purchased from ThermoFisher Scientific (USA). Flat-bottom,  96-microwell plates 
(untreated; 333-8013-01F) and sterile sealing tape (ST-3095) were obtained from 
Life Science Products (USA). A biotinylated, mouse monoclonal to nitrotyrosine 
antibody (anti-NTyr; ab24496, clone number CC22.8C7.3), streptavidin 
horseradish peroxidase (HRP; ab7403), and non-conjugated goat polyclonal anti-
human lactoferrin antibody (anti-LF; ab77548) were obtained from Abcam (UK). 
1.0 mL quartz cuvette with 10 mm path length (MF-W-10-LID) was purchased 
from Science Outlet (USA).  
Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate 




68.0 mM sodium chloride at pH 7.4), Tris-HCl buffer (Tris; 0.1 mM at pH 8.0), 
and carbonate buffer (29.0 mM sodium carbonate, 71.0 mM sodium bicarbonate at 
pH 9.6).  
The volumes of peroxynitrite used for production of NLFONOO- samples 
discussed in Section A. 2. 1 were 5.66, 11.36, 17.05, 22.73, 34.10, 45.46, and 
56.67 µL. Similarly, the volumes of TNM used for production of 
NLFTNM discussed in Section A. 2. 2 were 0.29, 0.58, 0.86, 1.16, 1.72, 2.32, and 
2.89 µL. These values correspond to molar ratios of nitrating agent to tyrosine 
(ONOO-/Tyr) or (TNM/Tyr) of 10/1, 20/1, 30/1, 40/1, 60/1, 80/1, and 100/1. The 
volumes of TNM used for production of NBSA discussed in Section A. 2. 4 and 
S.6.1 were 0.95 and 7.33 µL of 6/1 and 14/1. 
A.2 Micropipette precision  
The maximum precision reported for the variable volume, single channel 
micropipettes used  (VWR; USA) is ± 1.5-0.3% for the 2-20 µL pipette (89079-
964), ± 0.6-0.2% for the 20-200 µL pipette (89079-970), and ± 0.4-0.15% for the 
100-1000 µL (89079-974). The 12-channel micropipette (4662030) has a 
maximum precision of ± 2.0-0.3% for the 30-300 µL purchased from (Thermo 
scientific, USA). The coefficient of variation for the small transfer pipette with 
variable volume 0.1-2.5 µL (704769; Transferpette-S, USA) is 0.7%, and 0.5% for 




A.3 Purification of nitration reaction products  
 After nitration reactions were completed, selected samples were analysed 
before and after purification. 1.0 mL of NLF was purified using an Amicon Ultra 
centrifugal filter with a 30 kDa cut-off membrane and rinsed twice with 1.0 mL 
PBS buffer. The total concentration of LF in each sample was determined using a 
bicinchoninic acid assay, following kit instructions. The absorbance of each 
solution was measured in triplicate, and the protein concentration of each solution 
was determined by comparing against an eight point calibration curve generated 
using BSA standard in a concentration range between 25 and 2000 µg mL-1. 
A.4 Sandwich ELISA for optimization of polyclonal to lactoferrin antibody 
For the sandwich ELISA procedure, goat polyclonal to lactoferrin non-
conjugated antibody was used as the capture antibody and mouse monoclonal to 
nitrotyrosine biotinylated antibody was used as the detector antibody. Capture 
antibody was diluted in carbonate buffer in several dilution ratios (1:250, 1:500, 
and 1:1000). Three microwells were coated with 50 µL of each capture antibody 
dilution, and the plate was incubated at 4°C for 17 hours. The plate was washed 
and blocked as described in Section A. 2. 6.  
NLF (40/1 TNM/Tyr) was serially diluted into blocking buffer producing NLF 
solutions at seven concentrations (0.19, 0.39, 0.78, 1.56, 3.12, 6.25, and 12.5 µg mL-1). 
Thus, each of seven concentrations of NLF was aliquoted into 9 wells (three capture 
antibody dilution ratios X triplicate measurements) for ELISA treatment. After 




wells processed with capture antibody in each of the three dilution ratios and 
incubated for 2 hour at RT. Blocking buffer was added separately to three wells as 
a blank measurement. After washing, 50 µL the detector antibody, diluted 1:100 in 
blocking buffer, was added to each well and incubated for at room temperature for 
1 hour.  The assay was analysed spectroscopically using the procedure detailed in 
Section A. 2. 6. 
The polyclonal anti-LF capture antibody recognizes a specific peptide 
sequence (432-444: C-ENYKSQQSSDPDP) in the LF protein. The amino acid 
nomenclature used here: E (glutamic acid), N (asparagine), Y (tyrosine), K 
(lysine), S (serine), Q (glutamine), D (aspartic acid), P (proline).  
A.5 Purification is not required before quantification 
NLF produced using TNM also contains nitroformate as by-product, which 
has the same absorbance wavelength as NTyr (350 nm), which adds ambiguity to 
the interpretation of the NTyr spectral results. Figure A. 7 shows UV-vis 
absorbance and sandwich ELISA results for both purified and non-purified 
reaction products. Products before and after purification show similar trends. The 
absorbance intensity was slightly reduced after purification due to removing 
nitroformate by-product, but the sandwich ELISA result remain the same. We 
conclude that the purification process is not required for the sandwich ELISA 




A.6 Development and optimization of antibody usage   
A.6.1 Anti-NTyr detector antibodies (polyclonal or monoclonal) 
The initial step in the development of the NLF sandwich ELISA was to 
choose the anti-NTyr detector antibodies. We used direct ELISA to test nitrated 
bovine serum albumin (NBSA) using two different biotinylated nitrotyrosine 
antibodies: mouse monoclonal nitrotyrosine (ab24496) and goat polyclonal 
nitrotyrosine (ab27646). The monoclonal anti-NTyr antibody has increased 
specificity to binding at a specific epitope, compared to the polyclonal antibody 
that allows binding at multiple epitope, and thus allows sensitive quantification of 
antigens that contain the monoclonal epitope. NBSA was nitrated using two 
concentrations of excess nitrating agent (molar ratio of excess TNM to tyrosine of 
6/1 and 14/1). The monoclonal anti-NTyr exhibited higher sensitivity than the 
polyclonal anti-NTyr to detect NBSA produced at both TNM concentrations, as 
shown in Figure A. 1. 
A.6.2 Anti-LF capture antibody  
The polyclonal antibody (ab77548) considered here for the capture portion of the 
assay contains a peptide sequence that includes only one tyrosine residue, which is 
included in the iron-binding site (Steijns, et al. 2000). Teuwissen et al. reported that iron 
binding of LF was not reduced after nitration, which suggests that the tyrosine residues 
involved in the iron binding region will not be nitrated and, by extension, will not affect 
the binding to this specific antibody (Teuwissen, et al. 1973). The antibody under 




in immunoassays such as western blot, in human peripheral mononucleocytes, and 
using immunohistochemical assays for human tissues (Fahrbach, et al. 2013; de la 
Rosa, et al. 2008). Additionally, this capture antibody matches as a pair antibody to the 
anti-NTyr detector antibody previously chosen (Section A. 6. 1). Based on these piece of 
literature support, we tested the capture antibody via the ELISA. The results confirmed 
detection of NLF, supporting the assumptions stated above. A.6.3 Antibody sequence for 
the sandwich ELISA  
The polyclonal anti-LF contains a pool of immunogenic antibodies for the 
specific peptide sequence listed above (Section A. 4). This allows the anti-LF antibody to 
recognize the specific peptide epitope in multiple arrangements, thus increasing the 
probability that binding occurs between anti-LF and LF.  
Following the testing of the individual antibodies, the amplification of anti-
LF was tested for use in the sandwich ELISA using combinations of four 
antibodies: [a] goat polyclonal capture anti-LF (ab77548), [b] rabbit polyclonal 
detector anti-LF (ab25811), [c] rabbit polyclonal capture anti-NTyr (ab42789), and 
[d] mouse monoclonal detector anti-Ntyr (ab24496). The following antibody 
combinations were tested:  
(1) capture anti-LF [a] and detector anti-LF [b] 
(2) capture anti-NTyr [c] and detector anti-NTyr [d] 
(3) capture anti-LF [a] and detector anti-NTyr [d]  
Combination 1 (Fig. A. 2, red bars) show detection of LF, as expected because of 




bars) shows detection of NLF, which is expected because the antigen was nitrated 
using excess nitrating agent. This combination did not show detectable signal with 
pure LF, which is expected given that the capture antibody is specific for NTyr. 
Combination 3 (blue bars) shows detection of NLF, but very little in the LF case. 
All three combinations show very little detection of the blank (blocking buffer 
incubated under otherwise identical conditions). Combinations 1 and 3 both utilize 
the same capture antibody (anti-LF). The fact that combination 3 shows efficient 
detection of NLF, but combination 1 does not, suggests that the capture binding of 
antigen to antibody is not inhibited by antigen nitration. This may imply that the 
detector antibody binding is inhibited by nitration. The anti-LF capture antibody 
binds whether LF is the antigen (red bars, center) or NLF is the antigen (blue bars, 
right). The anti-LF detector also to LF (red, center), but not to NLF (red, right). 
We conclude from this study that using the anti-LF as capture antibody presented 
minimal reduction in binding sensitivity and that Combination 3 was viable for 




A.7 Supplemental Table and Figures 
Table A.1 Statistical tests comparing detection of NLF vs. LF. NLF concentration 
at each point from manuscript Figure A. 4 (dark yellow points) compared against 
LF mean (red line, 0.0187 ± 0.005 AU).
NLF concentration 
µg mL-1 p-value t-value 
0 0.26 1.15 
0.1875 0.0001 11.7 
0.375 0.0001 15.7 
0.75 0.0001 28.8 
1.5 0.0001 57.1 
3 0.0001 76.6 
6 0.0001 105 
12 0.0001 215 





Figure A. 1 Absorbance results from indirect ELISA using NBSA antigen nitrated at 
two ratios of TNM to tyrosine (6/1 and 14/1). Marker color indicates NTyr antibody used 
for detection NBSA antigen diluted into blocking buffer. The green marks represented 
mouse monoclonal nitrotyrosine (ab24496) and the red marks represented goat 
polyclonal nitrotyrosine (ab27646).Data points are mean values, with error bars 
as standard deviation of absorbance measurements from individual wells (n = 2). 





Figure A. 2 Absorbance results from sandwich ELISA testing efficacy of chosen 
antibodies: anti-LF capture (ab77548), anti-NTyr capture (ab42789, anti-LF 
detector (ab25811), and anti-NTyr detector (ab24496). Antigen selection shown on 
x-axis legend: Blank (PBS buffer), LF, and NLF (40/1 TNM/tyrosine). Each 
antigen used at 0.5 µg mL-1. Order of antibody placement in ELISA indicated in 
legend. Bars are average values, with error bars as standard deviation of 






Figure A. 3 Conceptual model for the antibodies sequence of NLF sandwich ELISA. 
Shown from bottom to top: non-conjugated anti-lactoferrin (anti-LF) as capture 
antibody (randomly oriented), NLF as antigen, biotinylated anti-nitrotyrosine 
(anti-NTyr) as a detector antibody, and streptavidin conjugated to HRP. Figure 





Figure A. 4 Dilution ratio plot for anti-lactoferrin and shows ELISA well absorbance at 
four dilution factors (anti-LF into blocking buffer). Data points are mean values ± 





Figure A. 5 Sandwich ELISA of NLFTNM (a) and NLFONOO- (b). Error bars show 





Figure A. 6 The absorbance of NLFTNM (a) and NLFONOO- (b). Legend value 






Figure A. 7 The absorbance of non-purified NLFTNM (a-b: top panels) vs. purified 
NLFTNM (c-d: bottom panels). Legend value on panels in left column (UV-vis results) 





Appendix B: Extraction and quantification of LF from animal cornea 
The following appendix includes preliminary research results toward quantify LF 
from animal tissue. A summary of the results and analysis are obtainable here as a 
documentation of my research in animal tissue which will help with future research.   
B.1 Overview 
Our project is investigating the effect of the nitration process that plays a role in 
diseases such as ocular disease.  We will begin this study by performing in-vitro 
experiments on corneal lamb tissue which will help us investigate changes in the eye 
without requiring in-vivo experimentation.   
The first experimental group will be the control group from which we will extract 
specific proteins (i.e. lactoferrin).  To the second experimental group we will apply 
liquid-phase nitration reactions and extract the proteins to measure the extent of the 
nitration on the proteins. See chapter 3. 
The goal of this project is to investigate the proteins changing due to nitration 
reaction on the cell level which will help us to understand the nitration of these proteins 
en route to understanding their potential importance in ocular diseases.   
B.2 Materials and methods 
Bovine cornea (age: 12-30 months, mixed gender) and rat cornea (age: 7-8 weeks, 
mixed gender) purchased from Pel-Freez Biological (AR, USA). Lamb cornea (age: 3 
months, male gender) donated from local butcher store (Jerusalem Market, E. Illif Ave.), 




ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES; 
H3375),  bicinchoninic acid Assay (BCA), Triton X-100 (X100), 
ethylenediaminetetraacetic acid anhydrous, bioultra (EDTA) , and  sodium chloride 
(S9625) were purchased from sigma-aldrish (USA). HALT (tm) protease inhibitor (PI; 
QB203967A) from fisher scientific company (PA, USA).  
Nitration reactions tetranitromethane (TNM), Sodium peroxynitrite (ONOO-), Amicon 
Ultracentrifuges tube cutoff 30K, Carry Bio 100 UV-vis spectrometer, and Carry eclipse 
Fluorescence spectrometer . 
The buffers used are: extraction buffer (EB) solution (50.0 mM Tris-HCl, 10.0 
mM HEPES, 150.0 mM NaCL, 5.0 mM EDTA, 0.5 % Triton at pH 7.7, and then fresh 
add 10 % PI) and Tris-HCl buffer (Tris; 50 mM at pH 8.0). 
Human milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030), 
tetranitromethane (TNM; T25003), Tween®20 buffer (P1379), Trizma base (Tris-
HCl; T1503), sulfuric acid (H2SO4; 320501), sodium phosphate dibasic 
(RES20908-A702X), potassium chloride (P9333), sodium chloride (S9625), 
potassium phosphate monobasic (P5655), sodium carbonate (S7795), sodium 
bicarbonate (S5761), Ammonium persulfate (APS; A3678), glycine (G8898), 
glycerol (G5516), acetic acid (320099), methanol (34860), Sodium dodecyl sulfate 
(SDS; L3771), and ethanol (245119) were obtained from Sigma Aldrich (USA). 
Sodium peroxynitrite (NaONOO; 516620), Amicon Ultra-0.5 centrifugal filters 
(30 kDa, 0.5 mL size; UFC503008), and Amicon Ultra centrifugal filters (30 kDa, 




3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and bicinchoninic acid 
assay (BCA; 23225) for total protein quantification were purchased from 
ThermoFisher Scientific (USA). Flat-bottom, 96-microwell plates (untreated; 333-
8013-01F) and sterile sealing tape (ST-3095) were obtained from Life Science 
Products (USA). A biotinylated, mouse monoclonal to nitrotyrosine antibody (α-
NTyr; ab24496), streptavidin horseradish peroxidase (HRP; ab7403), and non-
conjugated goat polyclonal anti-human lactoferrin antibody (α-LF; ab77548) were 
obtained from Abcam (UK). 1.0 mL quartz cuvette with 10 mm path length (MF-
W-10-LID) was purchased from Science Outlet (USA).  
Iron(III) chloride hexahydrate (FeCl3.6H2O; 236489), Nitrilotriacetic acid (NTA; 
N9877), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020), Tryptic Soya broth 
(TSB; 22092), and Tryptic Soya agar (TSA; 22091) were obtained from Sigma Aldrich 
(USA). 100mmx15mm petri dish with grip ring, sterile (229692) providate from 
CELLTREAT (USA). Uv 96-microwell plates with transparent flat bottom (3635) was 
purshaced from CORNING (USA). Escherichia coli (E. coli; ATCC25922) was 
purchased from the American Type Culture Collection, ATCC (USA). Precision-plus 
protein dual color standard (ladder; 1610374), 30% acrylamdie 29:1 (1610156), 
Tetramethylethylenediamine (TEMED; 1610800), Precision Plus Dual Color 
Standards (1610374), and Coomassie blue R250 (1610436) BIO-RAD (USA). 
Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate dibasic, 
0.8 mM sodium phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM sodium 




sodium carbonate and 71.0 mM sodium bicarbonate at pH 9.6), loading buffer ( 200 mM 
tris-HCl pH 6.8, 400 mM  dithiothreitol (DTT), 0.4% bromophenol blue, 40% glycerol 
and 8% SDS), running buffer (25 mM Tris-HCl, 192 mM glycine, and 0.1 % SDS), gel 
staining (coomassie blue R250 1%, acetic acid 10%, methanol 50%, and 40% water), gel 
destine buffer (50% methanol, 10% acetic acid, and 40% water), and Ferric 
nitrilotriacetate (Fe(NTA)2) solution (FeCl3.6H2O 4.0 mM and NTA 8.0 mM and 1 N 
HCl add 2% to total solution volume at pH 4.0), and the tryptic soya broth, and 
tryptic Soya agar was prepared following the manufacture instructions. SDS-
PAGE gel containing 3.2 % stacking gel (30% Acrylamide 266.7 µL, Tris-HCL 
(1.5M) 312.5 µL, 10% SDS 25 µL, water 890.8 µL, APS 50 µL, and TEMED5 
µL) and 10 % running buffer (30% Acrylamide 4166.7 µL, Tris-HCL (1M) 3125.0 
µL, 10% SDS 125 µL, water 5070.8 µL, APS 125 µL, TEMED 12.5 µL). 
B.3 Dissection of the cornea 
B.3.1 Lamb cornea 
The steps for lamb eye dissection to separate the cornea are as follows:  
a. Washed the eye from the blood using water, washed first and Tris-HCl second 





Figure B. 1 The whole lamb eye after washed and dried.  
b. The fatty tissue and muscles around the eye were removed using surgical scissors, 
see Figure B. 2.  
 
Figure B. 2 Removing the fatty tissue and muscle around lamb eye.  
c. The eye was silted using a surgical razor blade and then the point of the scissors 
was inserted into the slit and cut the eye sclera all the way around to get the eye 
into two halves. Each half of the eye was washed with Tris-HCl to remove the 
vitreous humor liquid that released after cutting the eye. The eye lens and iris 





Figure B. 3 The lens (1) and iris with pupil (2) were separated from the front side of the 
lamb eye.  
d. After detaching the lens and iris, the cornea was cut from the eye hemisphere 
using scalpel. The eye section and the tools used are shown in Figure B. 4 below.  
 
Figure B. 4 The sections of the eye after dissection are; cornea (1), lens (2), iris (3), 
connective tissue around the cornea (4), half of the back side of the eye with the optic 
nerve, fatty tissue, and muscle around the eye (6), and the tools were used in the right 
side.  
e. The lamb corneas were cut into four pieces and weighed, then snap frozen the 




B.4 Bovine and rat corneas 
The bovine and rat corneas were purchased, as previously separated from the 
vendor and cut into four pieces using razor blade and weighed. Then snap frozen the 
tissue and stored at -20 ºC until lysate extraction process.    
B.5 Tissue lysate from lamb, bovine, and rat 
The cornea tissue was lysate using the follows protocol. The tissue was placed in 
the microtube and EB 10 % of tissue mass was added. Next, it was rotated at the cold 
room for 25 minutes and then sonicated at 8 powers for 2 minutes in ice. Finally, the 
mixture was centrifuged at 1400 g for 30 minutes in the cold room. The supernate was 
collected and aliquot in cryogenic microtube and store in -20 ºC until further analysis. 
B.6 Qualitative analysis for tissue lysate  using spectroscopy analysis  
B.6.1 Quantification the total protein using BCA  
The BCA used to quantify the total amount of the proteins from cornea lysate 
following the manufacture instruction. 
B.6.2 Determination of protein using UV-vis and EEM  
Quartz cuvette was used for spectroscopy analysis. Carry BIO 300 spectroscopy 
was used to detect the scan absorbance of protein at wavelength 230-500 nm. Carry 
eclipse spectrophotometer was used to detect EEM at excitation wavelength 200-500 nm 




B.7 Quantitative analysis for LF from tissue lysate  
B.7.1 Sandwich ELISA 
Sandwich ELISA was used to quantify LF protein using the following protocol: 
The goat polyclonal to lactoferrin non-conjugated antibody (α-LF-n) was used as 
the capture antibody, and rabbit polyclonal to lactoferrin biotinylated antibody (α-
LF-B) was used as the detector antibody. An optimal dilution ratio of 1:5000 
capture antibody to carbonate buffer was followed from the abcam manufacturer 
recommendation. Microwells were coated with 50 µL of the diluted capture 
antibody and incubated at 4°C overnight.  After incubation, the wells were washed by 
adding 200 µL of PBST (PBS with 0.05% Tween) to each well and tapping the plate 
upside down on a laboratory wipe to remove excess buffer, repeating twice. Each 
subsequent incubation step also followed a similar process of sealing, followed by 
continuous shaking during the incubation period using a rocking platform (UltraRocker, 
BIO-RAD), and then duplicate washing with PBST. LF was serially diluted into 
blocking buffer producing LF solutions at eight concentrations (0, 0.24, 0.48, 
0.097, 1.95, and 3.90 ng mL-1). After a second washing step, 50 µL of each of the 
five LF solutions were added in triplicate to the plate and incubated at room 
temperature for 1 hour. Blocking buffer was used for blank measurements. 50 µL 
of the detector antibody, diluted in blocking buffer to a ratio of 1:1000, was then 
added, and the plate was incubated with shaking at room temperature for 1 




described above. The standard calibration curve was made according to the 
absorbance at each concentration of LF. 
B.7.2 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for 
molecular weight determination 
LF (1 mg/mL), bovine, lamb, and rat cornea lysate in PBS were heated at 90°C 
for 8 min, containing loading buffer 1:1 dilution. The SDS-PAGE protocol followed by 
U. K. Laemmli, the mini gel performed on discontinuous buffer gel of - 3.2% stacking - 
10% running polyacrylamide.(Laemmli 1970)  The stacking 3.2% has large pore size 
which will increase the protein resolution before separating it onto running gel. The 
running gel 10% has good separation for the range of 80 kDa molecular weight protein. 
B.8 Results and discussion 
B.8.1 BCA assay 
The cornea total proteins was detected and the result shows that the increased in  
total protein direct proption with the increase of the size of the cornea as shows in Figure 





Figure B. 5 The BCA calibration curve (A) used to detect the total protein in animal 
cornea (B).  
B.8.2 UV-vis 
The absorbance at 280 nm was detected in all cornea lysate and LF spectra used 
for comparison. The absorbance intensity at 280 nm was increased with the increased in 






Figure B. 6 The absorbance spectra of LF 1mg/mL used as control (A), rat absorbance is 
10 times higher than LF (B), lamb absorbance is 20 times higher than LF (C), and bovine 
absorbance is 30 times higher than LF (D).  
B.8.3 EEM 
The fluorescence spectra EEM used to detect multiple emission intensity for 
multiple excitation wavelength. The EEM of LF used as positive control, rat lysate, lamb 







Figure B. 7 The EEM spectra of LF 1mg/mL (A), rat (B), lamb (C), and bovine (D).  
B.8.4 SDS-PAGE  
The routine SDS-PAGE protocol is a sensitive technique for the analysis of protein 
components of a matrix and was used with gel stained by coomassie blue and silver stain. 
The gel was scanned using an Epson scanner to provide the resultant image. Figure (B. 8. 
A) shows an example result where rat LF has a band lower than the bovine and lamb LF 
because of the low concentration. Also, we detected the relative intensity using imageJ 







Figure B. 8 (A) SDS-PAGE with Coomassie blue stain, (B) the relative intensity of gel 
bands.  
B.8.5 Sandwich LF ELISA 
To detect LF concentration in animal cornea lysate, sandwich LF ELISA 
was used. The Figure B. 9 shows that the LF increase with the increasing of the 









Figure B. 9 (A) Sandwich ELISA calibration curve of human milk LF, (B) the bar graph 
for quantify cornea concentration.  
B.9 Summary 
Sandwich ELISA was used to quantify LF in animal cornea. The LF 
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Appendix C: Ergo experimental plan  
The following Figure C. 1 represented Ergo research plan for protein nitration. 


































Appendix D: Kirby Bauer assay 
D.1 Materials 
Glycerol stock of Escherichia coli (ATCC25922) or Streptococcus faecalis (ATCC 
19433) was inculcated into 4 mL Tryptic Soya agar (TSA) (Sigma Aldrich 22091) and 
incubated at 37ºC for 24 hrs. Then a few separate colonies 3-5 were selected and transferred 
into Tryptic Soya broth (TSB) (Sigma Aldrich 22092) and incubated at 37ºC for 24 hrs. 
Muller Hinton agar (MHA) (Sigma Aldrich M9552) was plated and storage in 4ºC until 
use. The plate has to incubate at 37ºC for 30 min before the assay. Then, 3 µL of the bacteria 
transferred directly into Muller Hinton agar plate and spread homogenously. The plate was 
dried for 3-5 minutes before the disc add. Blank disc (Remoel CT0998B) was loaded with 
20 µL of the sample and placed into MHA plate and gentle press was applied to the disc 
before incubated at 37ºC for 24 hrs.     
Test several growths Agar to improve the assay such as Tryptic Soya agar, Luria 
Broth Agar, and Muller Hinton agar. Then, many broths were tested in bacteria growth 
such as Tryptic Soya broth, Luria Broth, and Brain Heart broth. Test LF concentration 0.1-
1 mg/mL in water and PBS.    
Aim of Kirby Bauer (KB) study: To investigate antibacterial activity using zone of 







Zone of inhibition is the area around the disk that get affected by the antibiotic. 
D.2 Methods 
1 µL of glycerol stock aliquot of Escherichia coli (ATCC 25922) was inculcated 
Tryptic Soya agar (TSA) (Sigma Aldrich 22091) plate and incubated at 37ºC for 24 hrs. 
Then a few separate colonies 3-5 were selected and transferred into 4 mL Tryptic Soya 
broth (TSB) (Sigma Aldrich 22092) and incubated at 37ºC for 24 hrs. After incubation 
dilute this 4 mL into 50 mL TSB to make E.coli stock. The samples were placed into 96-
microwell plate and 200 1 µL per well was used. All samples was prepared in TBS, (Blank) 
is TSB, (positive control) is chloramphenicol antibiotic in 60 µL mL-1, LF and NLF was 
diluted it into 1mg mL-1. Then 5 µL of E. coli stock was added to each well and incubated 
at 37ºC for overnight. Finally, microwell plate was detected by the plate reader (Tecan 






The agar plate showed the zone of inhibition of LF vs. NLF 10/1, NLF 20/1, NLF 
30/1, NLF 40/1. The increase of nitration direct associated to the decrease of the zone of 
the inhibition, see Figure D. 1.  
 
Figure D. 1  Three agar plates showed the antibacterial affect using zone of inhibition for 
LF vs. NLF 10/1, 20/1, 30/1, and 40/1. 
  
Sample 10uL- E.coli 20uL- E.coli 5uL- E.coli 
LF  Not clear  18 mm  17 mm  
NLF 10/1  Not clear  15 mm  11 mm  
NLF 20/1  Not clear  15 mm  10 mm  
NLF 30/1  Not clear  14 mm  10 mm  




Appendix E: Buffer pH changed the nitration product yield  
This study helped us to test the effect of the buffer pH in nitration reaction using 
TNM. 
Figure E. 1 represents the absorbance spectra of BSA (TNM) nitration product 
using several buffers with different pH. The nitration reaction product increase with the 
increase of the buffer pH and the pH 12 buffer showed highest nitration peak at 
wavelength 350 nm. Also, no shift was observed in the nitration product peaks see Figure 
E. 1. Our concern was between Tris-HCl and PBS because they were the main buffers we 
used in TNM nitration reaction and both have similar nitration products.  
 
 




Appendix F: Comparison study of nitration reaction of aromatic amino acids using 
ONOO- and TNM 
 
This study is a side project that helped to analyze the absorbance and EEM 
spectra for nitrated protein.  
The following four set of Figures F. 1-4 showed the affect of nitration agents in 
free aromatic amino acid (Tryptophan, Tyrosine, Phenylalanine, and Histidine) and how 
that changes the  optical properties.  Our results matched the previous study by Mayer et 
al. for native amino acids for EEM analysis (Meyer, et al. 2015) and for absorbance from 
(Saidel, et al. 1952). 
F.1 Tryptophan (Trp) and nitrated tryptophan (NTrp)  
Trp as a native form has the highest absorbance and  fluorescence intensity among 
aromatic amino acids. Figure F.1. A showed an absorbance band in 280 nm for Trp and 
two bands after nitration at 280 and 350 nm. Figure F.1 Figure F.1. B showed 
fluorescence intensity between 300-450 nm for Trp and it is reduced after nitration. 
 The nitration agents TNM and ONOO- have different amino acids mechanism in 
nitration but they all share producing nitrotyrosine. The TNM agent nitrated aromatic 
amino acids but produced mostly nitrotyrosine which explain the more reduction in EEM 
intensity than ONOO-. Also, ONOO- has oxidation affect to cystine and methionine 











Figure F. 1  (A) Absorbance spectra for (B)EEM spectra for Tyr before (top) and after 






F.2 Tyrosine (Tyr) and nitrated tyrosine (NTyr)  
Tyr as a native form has the second highest absorbance and  fluorescence 
intensity among aromatic amino acids.  Figure F. 2. A showed absorbance band in 270 
nm for Trp and two bands after nitration at 270 and 350 nm. Figure F. 2. B showed 
higher fluorescence intensity between 280-350 nm for Tyr and it is reduced after 
nitration. As mentioned above the nitration agents TNM and ONOO- have different 
amino acids mechanism in nitration, but they all share producing nitrotyrosine. The TNM 
agent produced mainly nitrotyrosine and nitrotryptophan which explain the greater 
reduction in EEM intensity than ONOO-. Here ONOO- reduced the fluorescence intensity 
between 280-350 nm and generated a strong intensity between 380-500nm which related 
to dityrosine as a product of ONOO-.(Goldstein, et al. 2008) Also, the fluorescence range 









Figure F. 2  (A) Absorbance spectra and (B)EEM spectra for Trp before (top) and after 






F.3 Phenylalanine (Phe) and nitrated Phenylalanine (NPhe)  
Phe as a native form has the lowest absorbance and fluorescence intensity among 
aromatic amino acids.  Figure F. 3. A showed absorbance band at 260 nm for Phe and 
two bands after nitration at 260 and 350 nm. Figure F. 1. B showed low fluorescence 
intensity between 280-300 nm and it is reduced after nitration. The nitration products 










Figure F. 3  (A) Absorbance spectra and (B)EEM spectra for Phe before (top) and after 






F.4 Histidine (His) and nitrated Histidine (NHis)  
Figure F. 4. A showed His nitration band at 350 with ONOO- and no absorbance 
band with TNM. Figure F. 4. B His as a native form does not have fluorescence intensity 
and that matched to previous EEM study (Meyer, et al. 2015) which make it hard to 








Figure F. 4  (A) Absorbance spectra and (B)EEM spectra for His before (top) and after 






Appendix G: Infrared spectroscopic analysis for test functional groups of lactoferrin 
nitration 
The following IR spectra used to investigate the fictional group of lactoferrin and 
nitrated lactoferrin.  
 





Figure G. 2  IR spectra LF-Fe vs. NLF10/1-Fe, and NLF10/1-Ergo 1.0 mM-Fe. 
Figures G. 1 and 2 showed the functional groups that shows in the IR spectra for 
lactoferrin nitration samples 5mg/mL concentrations with and without Fe+3. The spectra 
bands described as: amid I band 1700-1600 cm-1, amid III band 1229-1301 cm-1 for CN 
stretching and NH bonding, amid B band 3300 cm-1 for NH stretching, amid B band 3300 





Appendix H: Iron binding analysis 
H.1 Method: Iron titration to detect iron-binding capacity 
The iron-binding assay was prepared following procedures outlined by Hamilton 
et al. (Hamilton, et al. 2009). After nitration reaction samples were purified, each 
UV-microwell was coated with 200 µL of either LF, NLF 10/1 NLF 40/1, NLF10/1- 
Ergo 0 .1, and NLF10/1- Ergo, 0.5 mM.. To each well, 1 equivalent of Fe(NTA)2 was 
added, and the absorbance was measured using the plate reader after five minutes of 
waiting at room temperature. Another equivalent of iron was then added and the process 
was repeated until a total of nine equivalents had been analyzed. The absorbance of each 
well was detected using the plate reader at wavelength 470 nm. 
H.2 Result: Iron-binding strength of LF and NLF 
To determine the strength of the binding affinity from both unmodified and 
nitrated LF to Fe3+, equivalents of Fe(NTA)2 were titrated into solutions of LF, NLF 10/1 
NLF 40/1, NLF10/1, NLF10/1- Ergo 0 .1,and NLF10/1- Ergo, 0.5 mM. Absorbance of 
the resultant solutions were measured at 470 nm (Fig. H. 2), where increasing absorbance 
indicates additional iron bound within the protein after addition to the ferric ion (Fe3+), 
according to Figure H. 1.  
Fe3++ LF - LFFe3+ + 2H+
 







Figure H. 2 Identified iron binding activity of absorbance spectra of iron titration for LF, 
10/1 NLF, an 40/1 NLF in spectra (A), , NLF10/1, NLF10/1- Ergo 0 .1,and NLF10/1- 





The absorbance of iron binding represented in (Figure H. 2, graph A). The binding 
strength was tested for each sample using absorbance at wavelength 470 nm. There were 
no significant differences in iron binding for LF comparing to NLF 10/1 and 40/1. Same 
results for Ergo, there were no significant differences between NLF10/1, NLF10/1-0 
Ergo.1, 0.5 mM and LF in (Figure H. 2, graph B). This finding suggested that the LF 





Appendix I: Denaturing study of LF and NLF 40/1-(TNM) using guanidine in four 
different concentrations 0.25, 0.5, 1.0, and 2.0 M 
The guanidine used to test the denaturing difference between LF and NLF 40/1. 
The denature effect of guanidine was examined using two techniques: EEM and SDS-
PAGE. 
I.1 SDS-PAGE 
The SDS-PAGE (Figure I. 1) showed one strong band for LF-Guanidine 0.25, 0.5, 
1.0, and 2.0 M at molecular weight 75kDa. There were two strong bands for NLF 40/1-
Guanidine 0.25, 0.5, 1.0, and 2.0 M around 75 kDa and one at 50 kD. There is missing 
band for LF 0.5 guanidine due to technical error.  
These bands indicate the structure change of NLF 40/1 from LF due to the 
different response with the denature agents. 
 
Figure I. 1 The SDS-PAGE stained with silver nitrate. The bands were presented  ladder, 






The guanidine fluorescence was tested as background for the detection and does 
not show fluorescence properties (Figure I. 2).  
 
Figure I. 2 The EEM of guanidine 2.0 M. 
The EEM for LF at wavelength range 300-350 nm showed decrease in 






Figure I. 3 The EEM of LF and guanidine in four concentrations. 
The EEM for NLF 40/1 at wavelength range 300-350 nm decrease as the 
guanidine concentration increase (Figure I. 4).  
The behavior of LF comparing to LF 40/1 were different which indicate structure 





Figure I. 4 The EEM of NLF 40/1 and guanidine in four concentrations. 
 
